Boring History for Sleep - Boring History For Sleep | The Tragic High of 1920s Paris 💋💉

Episode Date: October 18, 2025

🎷💄 Paris in the 1920s was the world’s hangover and after-party rolled into one. The war was over, jazz was everywhere, and half the city was convinced heroin was just “creative inspiration in a bottle.” Artists, poets, and party people called it enlightenment—doctors called it a terrible idea.From smoky Montmartre clubs to glamorous salons where everyone was either painting or passing out, the heroin craze turned the City of Light into a glittering, tragic blur.So close your eyes and drift through a world of jazz, perfume, and questionable life choices—where everyone was chasing art, love, and the next high.👉 Boring History For Sleep | Paris, pain, and the prettiest disaster in history.

One, two, a one, two, three, four. Give me a break, give me a break, break me off a piece of that Kit Kat bar. Give me a break. Give me a break. Break me off a piece of that Kit Kat Bar. Give me a break. Give me a break. Break me off a piece of that Kit Kat bar.

Have a break. Have a Kit Kat. This episode is brought to you by Netflix. Most valuable promotions in Netflix are hosting a Blockbuster Triple Headliner Saturday, May 16. Ronda Rousey returns to face fellow woman's MMA pioneer Gina Carano in the main event. Plus Co-Maine's Nate Diaz versus Mike Perry. And the best have you wait in the world, Frances Ngano versus Felipe Lins. Watch Rhonda Rousey versus Gina Carrano, live only on Netflix.

Saturday, May 16th at 9 p.m. Eastern Center Time, 6 p.m. Pacific Time. Hey there, truth seekers. Tonight we're walking into 1920s Paris, the city of lights, art, jazz, and wait for it. Heroin cough syrup you could grab at any corner pharmacy. No prescription needed, no questions asked. While Americans were drowning in prohibition chaos, Parisians were legally sipping heroin mixtures marketed as innocent remedies for your annoying cough or frazzled nerves.

Artists, tourists, expats. They all flooded into this glittering laboratory of modernity, hunting inspiration and freedom. Nobody suspected the real trap waiting inside those elegant apothecary bottles. So here's the question that'll keep us up tonight. How did a harmless medicine transform the world's capital of culture into the architect of a global addiction nightmare? Before we dive in, smash that like button if you're ready for this rabbit hole, and drop a comment, where are you watching from right now? Paris, New York, some random village at 3am.

I need to know who's brave enough to take this journey with me. All right, dim those lights, grab your headphones, and let's step through the looking glass into the Paris they never taught you about. in art history class. This one's going to sting. Ready? Let's go. Picture this. You're strolling down the Champs Elyse on a crisp autumn afternoon in 1924. The boulevards are gleaming. The cafe terraces are packed with artists debating Dadaism over absent substitutes. And the architecture, oh, the architecture is doing that thing Parisian buildings do, where they look like they were designed by angels with impeccable taste and unlimited budgets. You pass a pharmacy. Not some back-alley operation with flickering gas lamps and questionable hygiene standards, but a proper establishment.

Marble counters, brass fixtures polished to a mirror shine, large glass windows displaying rows upon rows of elegant bottles, each one looking like it could contain the elixir of life itself. The sign above the door isn't hand-painted on rotting wood, it's professionally engraved, possibly even illuminated. This is respectability incarnated in retail form. You walk inside because you've had this nagging cough for weeks now, and frankly, it's getting embarrassing at the opera. The interior smells of lavender and something vaguely medicinal, but not unpleasant. Behind the counter stands a gentleman in a pristine white coat, looking every bit like he graduated top of his class from some prestigious pharmaceutical academy. He's not your neighborhood drug

dealer, though. Spoiler alert. The distinction is about to get remarkably blurry. He's a professional, a man of science. He probably knows Latin. When you mention your cough, he nods with the kind of sympathetic understanding that cost extra in today's healthcare system, reaches behind him and produces a small glass bottle filled with amber liquid. The label is a masterpiece of early 20th century graphic design, elegant typography, perhaps a subtle art nouveau flourish, the pharmacy's name embossed in gold leaf. It looks like something you'd display on your mantelpiece, not hide in your medicine cabinet. Take two spoonfuls before bed, he advises, in a tone that suggests he's prescribed this a thousand times before. You'll sleep wonderfully, and that cough will be gone by morning.

The bottle contains heroin, not heroin adjacent or heroin-inspired or technically contains trace amounts that we're not entirely sure about. Actual diacetyl morphine, synthesized by buyer just a couple of decades earlier, and marketed with the kind of aggressive confidence that only a pharmaceutical company convinced it's discovered a miracle cure can muster. And you just bought it the same way you'd buy aspirin today, which is ironic, because buyer invented that too and originally pushed heroin as the safer alternative. Let that sink in for a moment. Heroin was considered the safe option. Aspirin was viewed with suspicion. Medical science in the 1920s was, shall we say, still figuring some things out. This wasn't some isolated

incident, some rogue pharmacist operating outside the bounds of civilised society, this was the system working exactly as designed. Heroin-based medications, syrups, tablets, elixas, lozenges, you name it, were stocked in virtually every pharmacy in Paris. They were advertised in newspapers, recommended by doctors, consumed by everyone from factory workers to aristocrats. The drug had been around for decades by this point, initially synthesised in 1874 by some ambitious chemist in London, who apparently thought morphine wasn't quite doing the job enthusiastically enough. Bayer commercialised it in 1898, slapped a catchy name on it, heroin from the German heroish, meaning heroic, because nothing says responsible pharmaceutical marketing, like naming your

product after its ability to make people feel invincible, and proceeded to sell it in over a dozen countries as a cough suppressant and cure for morphine addiction. Yes, you read that correctly. They marketed heroin as a treatment for morphine addiction. This is roughly equivalent to treating a gambling problem by introducing someone to high-stakes poker, but with worse withdrawal symptoms. By the time our story takes place in the mid-1920s, heroin had already established itself as a household staple across Europe and North America. But Paris Parry had elevated it to an art form, because if there's one thing Parisians excel at, it's taking something functional and transforming it into an aesthetic experience. They did it with Bruce.

bread, with wine, with fashion, with architecture, and naturally they did it with pharmaceutical-grade opioids. The city didn't just sell heroin. It packaged it, presented it, and integrated it into the very fabric of bourgeois respectability in a way that made addiction look less like a moral failing, and more like a lifestyle choice for the discerning modern individual. Let's talk about those bottles for a moment, because they deserve their own paragraph. These weren't generic brown-glass containers with smudged labels and vague instructions. These were objects of desire, carefully crafted to communicate safety, sophistication, and scientific legitimacy. The glass was pristine, often tinted in elegant shades of amber or cobalt blue,

to protect the contents from light degradation, a real concern, though it had the added benefit of making the bottles look absolutely gorgeous on your bathroom shelf. The labels were typographic marvels, printed with the kind of attention to detail usually reserved for wedding invitations or currency. Names like Syrop Heroic, Pastile Calment, Elixir Respiratory, each one sounding less like a narcotic and more like something Proust might have mentioned in passing, while describing an elegant soire. The French language has this remarkable ability to make anything sound refined, and pharmaceutical

companies exploited this ruthlessly. You weren't buying drugs, you were acquiring therapeutic preparations, you weren't getting high, you were. You weren't getting high, you you were addressing nervous exhaustion through modern medical intervention. The bottles typically came with elaborate instructions printed on the label, or included on a separate insert, written in language that straddled the line between medical authority and consumer accessibility. For persistent cough and respiratory discomfort, take one to two spoonfuls three times daily, after meals,

may induce pleasant drowsiness, operate heavy machinery with appropriate caution. That last bit was the 1920s equivalent of today's warning labels, except significantly more relaxed about the whole situation. Nobody was particularly worried about operating heavy machinery anyway, unless you count those newfangled automobiles, and honestly the roads were so empty compared to today that you could probably drive while moderately sedated and still have a lower accident rate than a modern Los Angeles freeway at rush hour.

Not that anyone should try that, just pointing out the relative chaos levels, the packaging extended beyond the bottle itself. Many preparations came in small cardboard boxes, again beautifully designed, often featuring images of healthy, rosy-cheeked individuals enjoying life free from the burden of coughs, anxiety, or any other ailment that might interfere with their ability to attend gallery openings or literary salons.

Some boxes featured art-neuvo illustrations of flowers, particularly poppies, because apparently subtle irony was lost on the marketing departments of pharmaceutical companies. Here's some opium derivative to cure what ails you and look. We've decorated the box with pictures of the plant we extracted it from. Isn't that charming? The cognitive dissonance was staggering, but nobody seemed particularly troubled by it. Inside these elegant boxes nestled in tissue paper or moulded cardboard inserts

sat the bottles or blister packs of tablets, each one a tiny promise of relief, comfort, and, though nobody wanted to admit it yet, the first step down a rather steeper unpleasant staircase. But we're getting ahead of ourselves. Let's stay in that pharmacy for a bit longer, because the architecture of this space tells us so much about how addiction was normalized, sanitised, and sold to an unsuspecting public. The pharmacy itself was a temple of modernity. The early 20th century was obsessed with progress, with science, with the idea that humanity had finally figured out how the world worked and could now engineer solutions to every problem. Pharmacies embodied this optimism. They were.

were clean, bright, organised. A stark contrast to the dark, cramped apothecaries of previous centuries where medicines were mixed in dubious conditions by people who might or might not have washed their hands since breakfast. These new establishments featured electric lighting, which was still relatively novel and impressive in the 1920s. The bulbs cast a clean, steady glow over the merchandise, making everything look clinical and trustworthy. none of that flickering, shadowy atmosphere you'd associate with, say, an opium den in Marseilles. This was respectable. This was scientific.

This was France showing the world how civilised society approached healthcare. The layout was deliberate. Heroin preparations weren't hidden in the back or sold from under the counter like contraband. They were displayed prominently, often at eye level, positioned among other common remedies. This placement was crucial. It normalized the products through proximity. When heroin syrup sits between a bottle of digestive tonic and some sachets for headache relief, your brain automatically categorizes it as medicine rather than dangerous narcotic.

The human mind is wonderfully lazy in this regard. It uses context clues to make rapid assessments, and if the context screams legitimate pharmacy, then everything within that context must be legitimate medicine. The fact that one of those bottles contains a substance that will eventually be classified as one of the most addictive drug, drugs known to humanity becomes irrelevant. It's surrounded by respectable remedies. Therefore, it must be a respectable remedy. This is the same psychological trick that makes people trust banks because they

have marble floors and makes airlines seem safer when their flight attendants wear pristine uniforms. Presentation matters, often more than reality. Behind the counter stood our pharmacist, and we should spend some time with him because he's a crucial character in this story. He wasn't some villain twirling his mustache and plotting how to get innocent perisions hooked on opioids. He was, in all likelihood, a decent person who genuinely believed he was helping people. He'd attended pharmaceutical school, studied chemistry and biology, learned about the latest medical research. He'd been taught that heroin was an effective cough suppressant, which, to be fair, it absolutely was, and still is. Opioids are phenomenally good at suppressing the cough reflex.

The problem, of course, is that they're also phenomenally good at hijacking your brain's reward system, creating physical dependence and generally ruining your life. But medical science in the 1920s was still working out these minor details. Our pharmacists probably recommended heroin preparations dozens of times per day. They worked. Patients came back happy, reporting that, yes, the cough was gone, they'd slept wonderfully, felt more relaxed than they had in months. Success stories. Everyone.

The fact that these same patients were, patients kept returning to buy more bottles, week after week, month after month, wasn't necessarily seen as concerning. After all, chronic coughs were common in an era before antibiotics, when tuberculosis was rampant and urban air quality was somewhere between problematic and actively trying to kill you. If someone needed ongoing medication, that was just the nature of their condition. The idea that the medication itself might be creating the need for more medication, hadn't quite penetrated medical consciousness yet, or if it had, it was being politely ignored in favour of the very profitable status quo. The transaction itself was remarkably

casual. You'd tell the pharmacist your symptoms. He'd nod knowingly, retrieve a bottle, tell you how much to take, you'd pay, and you'd leave. The entire interaction probably took less than five minutes. No prescription required, no background check, no concerned questions about your medical history, or whether you'd tried non-narcotic options first, just a simple commercial exchange, as unremarkable as buying bread at the boulangerie down the street. This ease of access was absolutely critical to how heroin proliferated through Parisian society. There was no barrier to entry, no moment of hesitation where you might think, is this a good idea? The system was frictionless, and friction is often what saves us from our worst decisions. Want to send an angry email?

The 30 seconds it takes to find someone's address might give you time to reconsider. Want to buy something expensive online. Having to enter your credit card details creates a pause for reflection. Want to start taking heroin in 1920's Paris. Here's a bottle. That'll be 12 francs. Have a lovely day. Let's follow a typical customer on their journey from that first purchase to regular use,

because this trajectory is crucial to understanding how addiction embedded itself in respectable society. We'll call her Marguerite. she could be Marcel or Marie Claire or anyone else. Names change, but patterns of dependency remain remarkably consistent. Marguerite is 28, works as a secretary at a law firm, lives in a modest apartment in the 11th arrondissement, and has been dealing with insomnia and nervous tension for months. The work is stressful, Paris is expensive,

and she's been feeling increasingly anxious about everything from her job security to international politics to whether she'll ever find a suitable husband. standard human worries, nothing exceptional. A colleague mentions that she's been taking this marvellous syrup for her nerves, bought it at the pharmacy on Rue de Rivoli. Absolute miracle. Sleeps like a baby now. Feel so much calmer during the day.

Would Marguerite like to borrow the bottle to try it? Just a spoonful before bed, see how it works. This is how it often started, not with some shady drug dealer in a back alley, but with a well-meaning friend sharing medication the way people today might share melatonin gummies or herbal tea. Casual, friendly, helpful. Marguerite tries it that night,

takes one spoonful of the amber liquid. It tastes vaguely sweet, slightly medicinal, not unpleasant. Within 20 minutes, she feels the most wonderful sense of relaxation spreading through her body. The constant low-level anxiety that's been her companion for months simply. Dissolves.

Her thoughts stop racing. The worries that usually keep her awake until two in the morning suddenly seemed distant and unimportant. She lies down, expecting the usual hour of tossing and turning, and instead falls asleep almost immediately. She sleeps deeply, dreamlessly, and wakes the next morning feeling genuinely refreshed for the first time in recent memory. This is the seductive part. Heroin, in those initial doses, feels like the solution to problems you didn't even realize you had. It doesn't make you feel high in the way people imagine drug use no hallucinations, no wild euphoria, no loss of control. It makes you feel

normal, but a better version of normal. Karma, more comfortable, like someone turn down the volume on all the unpleasant static that fills daily life. For someone dealing with genuine anxiety or insomnia or chronic pain, this feels like a medical miracle, and in a sense, it is. Opioids are incredibly effective at what they do. The problem is what they do to you in return. Marguerite returns the bottle to her colleague with effusive thanks and asks where she bought it. Next Saturday, her day off, she makes a trip to that pharmacy on Ruda Rivoli. It's a beautiful establishment, exactly as described earlier marble, brass, elegant displays. She feels a tiny flutter of nervousness asking for the syrup, but the pharmacist treats her request as completely routine, which it is.

He retrieves a bottle, explains the dosage, mentions that she should avoid alcohol while taking it, advice she'll follow carefully at first and then gradually ignore as she becomes more comfortable with the medication. She pays, tucks the bottle in her handbag, and walks out feeling pleased with herself for taking charge of her health in such a modern, scientific way. For the first few weeks, everything is perfect. She takes one spoonful each night before bed, sleeps wonderfully, feels calmer at work. Her boss even comments that she seems more focused lately. She's not taking enough to feel obviously sedated during the day, just enough to take the edge of her anxiety and ensure good sleep. This is functioning drug use, the kind that flies under everyone's radar because there are no obvious negative consequences yet. She goes to work, fulfills her responsibilities, maintains her social life and happens to take a spoonful of medicine each evening.

Millions of people today do essentially the same thing with prescription medications. The line between medical use and abuse is often invisible until you're already on the wrong side of it. But here's where the biology gets tricky, and this is true of all opioids, not just heroin. Your body is a remarkably adaptive system. It doesn't like being altered, so when you introduce a foreign substance that affects brain chemistry, your body starts making adjustments to compensate. It's trying to maintain equilibrium, which sounds helpful until you realise what this means in practice. The receptors in your brain that respond to opioids start to down-regulate.

There are fewer of them, and the ones that remain become less sensitive. Your body is essentially turning down the volume on the drug's effects. This is called tolerance, and it's the mechanism that drives most addiction cycles. After a month, Marguerite notices that one spoonful doesn't seem to work quite as well. She still falls asleep, but not as quickly, and she wakes up once or twice during the night. The calming effect is less pronounced. She's not anxious exactly, but that perfect sense of peace she felt initially has diminished. So she does what seems perfectly logical.

She takes a slightly larger dose, one and a half spoonfuls, problem solved, sleep improves again, the anxiety relief returns. She's just adjusting her medication to her needs, the way anyone might adjust the dose of any medicine. Nothing concerning here. Move along, except this starts a pattern. Every few weeks the dose that worked last month doesn't quite work this month, so she increases it. Two spoonfuls, then two and a half, then three. Within six months of that first

purchase, she's going through a bottle per week instead of per month. She's had to start visiting multiple pharmacies because she's mildly embarrassed about how frequently she's buying the same product from the same place, not because she thinks she has a problem, she's still very much in denial about that, but because she's worried the pharmacist might judge her, or, worse, refused to sell to her. though honestly that rarely happened. Pharmacists were running businesses and regular customers were good for business. As long as you weren't obviously intoxicated or causing a disturbance, they were happy to sell you whatever you wanted to buy, as often as you wanted to buy it. This is the architecture of addiction, not the physical architecture of the pharmacy, though that played its role, but the systematic architecture of escalation. Each step seems reasonable in isolation. Of course you'd take medication if you have insomnia,

Of course you'd increase the dose if it stops working. Of course you'd buy more bottles if you need them. Every individual decision makes sense. It's only when you step back and look at the trajectory that the problem becomes apparent and most people are too close to their own lives to step back far enough to see the pattern until they're thoroughly caught in it. Now Marguerite is taking the syrup multiple times per day, a spoonful in the morning to ease into the workday,

another at lunch to manage the afternoon stress, a larger dose before bed. She's spending a significant portion of her salary on it. She's lost weight because opioid suppress appetite, and while she initially enjoyed this side effect, weight loss was desirable in the 1920s, just as it is now, it's gone too far. Her colleagues are starting to comment.

She looks tired all the time, despite claiming to sleep well. Her performance at work is declining. She forgets things, misses details, shows up late with increasing frequency. The worst part is the mornings. She wakes up feeling awful sweaty, nauseous, anxious, achy all over. The moment she takes her morning dose, these symptoms disappear. She's convinced herself she has some kind of chronic illness, and the medicine is treating it.

It hasn't occurred to her, or she's refusing to acknowledge that she's experiencing withdrawal symptoms, and the medicine is causing the problem it's supposedly solving. This is the cruel paradox of opioid addiction. The drug stops providing much pleasure or relief after a while. But you need it just to feel normal, to avoid feeling absolutely terrible. You're not taking it to feel good anymore. You're taking it to not feel awful. You've crossed the line from used to dependence,

and there's no clear moment when that transition happened. It was gradual, invisible, inevitable. Let's zoom out from Margaret's individual story, though we'll return to her later and look at how this same pattern replicated across thousands of people in Paris during this period, because Marguerite wasn't an outlier. She wasn't uniquely weak-willed or predisposed to addiction. She was simply a normal person who encountered a highly addictive substance in a context that presented it as safe, legitimate and helpful. Change the name, adjust a few details, and her story could be that of a factory worker, an artist, a bourgeois housewife, a war veteran, a student, a prostitute.

Heroin was remarkably democratic in its destructive potential. It didn't care about your social class, your education, your moral character. It was happy to ruin anyone's life if given the opportunity. The pharmacies on the Champs-Elese were particularly important in this ecosystem, because of their location and clientele. The Champs-Elese wasn't just any street. It was and remains one of the most famous avenues in the world, a symbol of Parisian elegance and sophistication.

Pharmacies there catered to wealthy Parisians, tourists, expatriates. These were people with disposable income, leisure time, and a taste for modern conveniences. They were exactly the kind of customers who would embrace a new pharmaceutical product if it was presented correctly, and boy was heroin presented correctly. Imagine you're an American expatriate, part of that famous lost generation that flooded Paris in the 1920s. You're here because the exchange rate is favourable, the culture is stimulating, and prohibition back home has made staying in the States absolutely intolerable for anyone who enjoys a civil cocktail. You're probably a writer, or an artist, or a journalist, or you're just

independently wealthy and bored. You're living in a furnished apartment in Montparnasse, spending your evenings at cafes arguing about Hemingway's latest work, or whether Joyce has gone completely insane with this stream of consciousness business. You're having the time of your life, except for the fact that you're also deeply anxious, probably depressed, possibly traumatised if you served in the Great War, and definitely drinking too much even by the relaxed stand. of 1920's Paris. Someone at your favourite cafe, maybe it's the American girl

who sits in the corner writing poetry, or the British painter who's always covered in charcoal dust mentions that they've found, this wonderful medicine for nerves. Completely legal, you can buy it at any pharmacy, it's actually quite sophisticated, the French have such a sensible approach to these things.

Not like the prudish Americans with their absurd prohibition laws. You're intrigued. You're also willing to try almost anything that might quiet the constant mental noise that comes with being a self-exiled intellectual in a foreign city, where you're not entirely sure what you're doing with your life, but you're determined to have profound experiences while figuring it out. So you visit a pharmacy, probably one of those gleaming establishments

on the Champs-Elysé, because you've been walking there anyway, admiring the shop windows and pretending you can afford the clothes displayed in them. You ask for something for nervous tension. The pharmacist recommends several options, including a particular elixir that's very popular. You buy it, You try it, and suddenly, all that existential anxiety, all that unnamed dread, all that fear that you're wasting your life and your talent and your youth on a self-indulgent adventure that won't lead anywhere meaningful. All of it simply quiets down. Not gone, exactly, but distant, manageable. You can write without the paralyzing self-doubt. You can paint without the crushing fear of failure. You can exist without the constant background radiation of anxiety. This is transformative. This is what

you've been looking for. You tell your friends. They try it. They tell their friends. And suddenly your entire social circle is casually using heroin-based preparations, discussing them the way people today might discuss antidepressants or anti-anxiety medications. Oh, which brand do you use? I prefer the syrup from the pharmacy near the Luxembourg gardens. They have the most elegant bottles. Have you tried the lozenges? So much more convenient for travelling. These were actual conversations happening in Paris in the 1920s, spoken by educated, artistic, often quite brilliant people who had absolutely no idea they were developing severe drug addictions. The tourist angle was particularly insidious. Paris in the 1920s was flooded with visitors. The war was over, the world was ready to exhale,

and everyone wanted to see the city of light in its glory. Tourists would arrive, spend weeks exploring museums and cafes and shops, and inevitably they'd develop a cough or a headache or some minor ailment. They'd visit a pharmacy, buy some heroin syrup, feel amazingly better, and think, how marvellous French medicine is so advanced. Then they'd return home to London or New York or Chicago with a bottle or two in their luggage. Never mind that technically this was now illegal in many of their home countries. Customs agents weren't particularly vigilant about checking for pharmaceutical products, especially in sealed bottles with professional labels. It looked like medicine, therefore it was medicine. Some of these tourists would be.

develop a habit while still in Paris and then face the problem of how to maintain their supply once they returned home. This created an informal international smuggling network, not organized crime exactly, but a web of personal connections and small-scale trafficking. Someone in New York who'd gotten hooked during their Parisian adventure would write to a friend who was still living there, asking them to mail a few bottles. That friend would oblige because they were helping out a pal, not engaging in drug trafficking as far as they were concerned. money would be wired, packages would be mailed, international mail services became unwitting accomplices in feeding addiction across borders. This went on for years before authorities really started cracking down, and even then enforcement was spotty and half-hearted.

The aesthetic dimension of this whole enterprise cannot be overstated. We've talked about the bottles, but let's really dig into why they mattered so much. Humans are visual creatures. We make snap judgments based on appearance, an ugly, cheap, cheap, looking bottle with a handwritten label immediately triggers suspicion. It looks like something made in a basement, possibly poison, definitely not something you'd voluntarily ingest. But a beautiful bottle, professionally labelled, sitting on a shelf in an elegant pharmacy. That's art, that's science, that's civilisation. The bottle itself becomes a guarantor of safety and legitimacy. Pharmaceutical companies understood this instinctively. They invested in packaging design with the same care that perfume companies

invested in their bottles. Some heroin preparations came in containers that genuinely looked like luxury products, cut glass with decorative stoppers, embossed labels with gold foil. Some even came with their own measuring implements, tiny glass cups or ornate spoons, each one designed to make the act of taking the medicine feel refined, special, like a small ritual of self-care. This is psychological manipulation of the highest order, except nobody really understood that's what they were doing. They thought they were just presenting their products attractively, using good business practices. The fact that beautiful packaging made people more likely to buy, use and continue using a dangerously addictive drug was an unintended consequence, probably.

Actually, we should pause here and consider whether pharmaceutical companies knew what they were doing. This is a complicated question. By the early 1920s, medical literature was starting to document cases of heroin addiction. It wasn't a secret that the drug could be habit-forming. But there were significant disagreement about how serious the problem was, how easily it developed, and what to do about it. Some doctors argued that addiction only occurred in people with weak moral character or underlying psychological problems. Others maintained that heroin was perfectly safe if used as directed, and only became problematic when people exceeded recommended doses, a position that conveniently ignored the fact that tolerance and dose escalation were inevitable with regular use. pharmaceutical companies naturally sided with the heroin is fine if used responsibly camp.

They had significant financial incentives to do so. Heroin products were profitable, very profitable. Addiction created repeat customers who bought more and more product over time. Now, to be fair to these companies, though, they arguably don't deserve much fairness. They probably didn't set out with a deliberate plan to addict people for profit. But they certainly didn't examine the issue too carefully, pull products from the market when problems became apparent. They downplayed concerns, funded research that supported their position, and continued marketing heroin preparations aggressively even as

evidence of harm accumulated. This same playbook would be used by tobacco companies in the late 20th century and pharmaceutical companies with Oxycontin in the early 21st. Corporations have short memories but consistent strategies. Back to our pharmacies on the Champs-Elese. These establishments weren't just selling heroin, they were selling an entire lifestyle fantasy. The fantasy went something like this. You're a modern person living in the most exciting city in the world at the most thrilling moment in history. Science has unlocked nature's secrets and placed miraculous cures at your fingertips. You need not suffer from any ailment no matter how minor. Relief is available, elegant, affordable, without moral judgment or medical gatekeeping. You can manage your

own health, your own consciousness, your own experience of daily life. This is freedom. This is progress. This is what civilization looks like, and people bought it. Literally and figuratively, the pharmacies thrived, the pharmaceutical companies thrived. Paris developed a reputation as a place where you could obtain substances that were increasingly controlled or banned elsewhere. This reputation attracted not just regular users, but serious addicts, people fleeing stricter drug laws in their home countries, people who'd burned through their local supplies and needed new sources. The city became a kind of nexus point for opioid use in Europe, which is darkly ironic given that Paris was also simultaneously the cultural capital of the Western world, the place everyone looked to

for art, fashion, literature, philosophy, light and darkness, occupying the same space, and most people somehow failing to notice the contradiction. Let's return to the question of dose escalation, because this is where the truly dark architecture of addiction reveals itself. Remember Marguerite, our secretary? After about a year of regular use, she's taking what would be considered an enormous dose 10 or 15 times what she started with. She's spending most of her salary on heroin. She's had to borrow money from family members,

claiming she has medical expenses, which technically isn't a lie but certainly isn't the truth. She's lost her job due to poor performance and unreliability. She's tried to quit several times, making it a day or two before the withdrawal becomes unbearable, and she gives in and takes another dose. Opioid withdrawal is uniquely cruel. It's rarely fatal unlike alcohol or benzodiazepine withdrawal,

which can actually kill you, but it's so profoundly unpleasant that most people can't endure it without medical support. Imagine the worst flu you've ever had, combined with severe anxiety, depression, and a bone-deep aching that makes you feel like your skeleton is trying to escape your body. Now extend that over days or weeks. The acute phase typically lasts about a week, but psychological symptoms and sleep disturbances can persist for months.

During withdrawal, you're not capable of working, socialising or functioning in any normal capacity. You're just suffering, counting minutes until it's over, knowing that one dose would make everything stop immediately. This is the trap that kept people using long after they wanted to quit. It wasn't that they enjoyed heroin anymore. Most long-term users described the experience as just maintaining a baseline of not feeling terrible. The euphoria was gone, the relief was minimal, but stopping meant voluntary submission to extraordinary suffering, and humans are programmed to avoid suffering.

We'll do almost anything to escape pain, including continuing behaviours we know are destroying our lives. The pharmacists never mentioned this part. The beautiful labels didn't include warnings about severe physical dependence and agonising withdrawal. The pharmacists didn't ask if you'd considered the long-term consequences of daily opioid use. The whole system was set up to facilitate easy access without any of the necessary safeguards. It was consumer freedom taken to its darkest conclusion. You were free to destroy yourself, and commerce was happy to provide the tools. Some historians argue this was an innocent mistake, that medical science simply didn't know better.

I'm sceptical of that position. By the 1920s, there were decades of ever. evidence about opioid addiction. The problems with morphine were well documented. Thousands of Civil War veterans in the United States had become addicted to morphine administered for war injuries, creating what was often called soldiers' disease. Similar patterns emerged across Europe after various conflicts. The medical community knew addiction was real, severe and difficult to treat. What they lacked wasn't knowledge, but the will to act on that knowledge when doing so would disrupt profitable industries and challenge societal assumptions about personal freedom and pharmaceutical progress.

There's also a class dimension we need to address. When poor people used opioids, particularly when it was Chinese immigrants smoking opium in the late 19th century, that was seen as a moral crisis requiring immediate legal intervention. Laws were passed, dens were raided, users were arrested, but when middle class and wealthy prisons were consuming heroin from elegant pharmacies on the Champs-Elysé, That was medicine. That was self-care. That was nobody's business but the individuals. The drug itself wasn't that different heroin is just a more potent, fast-acting version of morphine, which is derived from opium. But the presentation, the context, the class of the user, those factors determined whether you were a degenerate engaging in drug abuse

or a responsible citizen managing their health with modern pharmaceuticals. This double standard persists today, though we like to pretend it doesn't. Prescription opioid addiction is treated with sympathy and medical intervention. Street heroin addiction is treated as a criminal justice issue. Same drug, same addiction mechanism, different social responses based largely on demographic factors and method of acquisition. The architecture of how we think about drugs was largely established in this era, and the foundations remain remarkably sturdy despite a century of evidence that maybe we should reconsider the whole structure.

Now let's pull back the elegant curtain of those Parisian pharmacies, and examine what was actually happening inside people's brains when they took that first spoonful of heroin syrup. Because the gap between what doctors thought was happening and what was actually happening was roughly the size of the Atlantic Ocean, and about as easy to cross with the scientific equipment available in 1924. Medical science in the 1920s was experiencing a golden age of confidence, paired with a somewhat embarrassing shortage of actual understanding, which is a dangerous combination when you're prescribing highly addictive substances to trusting patients who assume you know what you're doing.

Here's what doctors knew. Heroin worked. Spectacularly well. Give it to someone with a cough. The cough stopped. Give it to someone with anxiety. The anxiety dissolved. Give it to someone with insomnia.

They slept like they'd been hit with a cartoon mallet. Results were immediate, dramatic and consistent. From a clinical perspective, this looked like a miracle. drug. The problem, and this is where things get uncomfortably amusing in that dark historical way, is that doctors were confusing this makes symptoms disappear right now, with this is effective long-term therapy. Those are not the same thing, not even remotely. But medical science was still working out this distinction, preferably through large-scale human experimentation disguised as normal medical practice. Let's start with the basic neurochemistry, though we should

acknowledge up front that doctors in the 1920s understood maybe 15% of what we're about to discuss, and that's being generous. The human brain operates on a complex system of neurotransmitters chemical messengers that jump between neurons to transmit information. One of these systems involves endogenous opioids, which is a fancy way of saying, opioids your body makes naturally. Your brain produces compounds like endorphins and encephalins that bind to opioid receptors scattered throughout your nervous system. These natural opioids help regulate pain, reward, mood, and various automatic functions like breathing and digestion. It's an elegant system that evolved over millions of years to help humans survive and function. Then someone comes along and dumps diacetal morphine

into this carefully balanced system and things get interesting in the way that, interesting times, is actually a curse. Heroin is lipophilic, meaning it loves fat, and your brain is about 60% fat by dry weight, which makes it essentially a welcome mat for heroin molecules. The blood-brain barrier that semi-permeable border between your circulatory system and your brain that exists to keep potentially harmful substances out has a much easier time blocking water-soluble molecules than fat-soluble ones. Water-soluble morphine has to work a bit to cross this barrier. Heroin, with its added acetyl groups making it more fat-soluble, crosses this barrier like it has a VIP pass and the doorman owes it a favour. We're talking minutes here, sometimes seconds. This is why

heroin produces such a rapid and intense effect compared to morphine. It gets where it's going fast. Once inside the brain, heroin rapidly converts back into morphine and then into other active metabolites. These molecules flood your opioid receptors, primarily the mu-opioid receptors, though delta and kappa receptors get involved too binding to them with an affinity that makes your natural endorphins look weak by comparison. We're talking about a synthetic compound that's orders of magnitude more potent than anything your body produces naturally. It's like your brain has been listening to acoustic guitar its whole life, and suddenly someone plugs in a martial stack and cranks it to 11. The system isn't designed for this level of input. When heroin molecules bind to these receptors, they trigger a

cascade of effects. Pain signals get blocked. Dopamine, the neurotransmitter associated with reward and pleasure floods the nucleus accumbens, which is basically your brain's pleasure centre. Your amygdala, which processes fear and anxiety, quiets down. Your respiratory drive decreases, which is why heroin suppresses cough so effectively, and also why opioid overdoses kill through respiratory depression. Your digestive system slows, causing constipation, which is perhaps the least romantic side effect of any drug ever, but is nearly universal among opioid users. Essentially, heroin reaches into your brain's control panel and starts adjusting all the dials simultaneously

with no particular regard for whether this is a good idea long term. Now here's where the medical establishment in the 1920s demonstrated what we might charitably call interpretive creativity. Doctors observed that heroin made patients feel dramatically better, which it did. They noted that patients reported relief from their symptoms, which was accurate. They documented improved sleep, reduced anxiety, better mood, all real, measurable outcomes. Based on this evidence, they concluded that heroin was working as intended, providing therapeutic benefit with minimal downsides. This conclusion was technically correct for about the first week of use, and then it became progressively less correct with each

passing day, though many doctors either didn't notice or didn't want to notice this declining accuracy. The problem is that your brain isn't passive. It doesn't just accept these chemical intrusions and carry on as normal, your brain is an adaptive system that constantly tries to maintain equilibrium, a concept called homeostasis. When you introduce a substance that dramatically increases opioid receptor activation, your brain interprets this as, okay, clearly we have way too much opioid activity happening. We need to compensate. So it starts making adjustments. Opioid receptors begin to down-regulate their numbers decrease. They become less sensitive. The signaling pathways downstream of these receptors become less responsive. Your brain is essentially trying to turn down the volume

to compensate for the external noise you keep introducing. Additionally, and this is particularly devious, your brain starts to reduce its own production of natural opioids. After all, why bother making endorphins when there's plenty of opioid activity already? This is logical from your brain's efficiency-minded perspective but catastrophic for the user, because what happens when you've downregulated your receptors and shut down your natural opioid production, and then you stop taking heroin. You have way less opioid activity than normal, not just the absence of the drug's effects, but actual below-baseline opioid function. This is withdrawal, and it's why it feels so terrible. You're not just returning to normal, you're plunging below normal until your brain can slowly, painfully readjust. This adaptive process

is called tolerance, and it develops with remarkable speed for heroin. We're talking days to weeks, not months or years. The dose that worked perfectly on day one will be insufficient by week two. The dose that worked at week two will be inadequate by month two. This creates what medical professionals call dose escalation and what regular humans call needing more and more of this stuff just to feel okay. Doctors in the 1920s observed this pattern. Patients would return saying the medicine wasn't working as well anymore. And here's where the interpretation gets fascinatingly wrong. Many doctors interpreted this dose escalation as evidence that the underlying condition was worsening and required more aggressive treatment. Think about that logic for a moment. Patient comes in with a cough,

gets prescribed heroin syrup, cough goes away. Returns two weeks later saying they need a higher dose because the cough is coming back. Doctor concludes the cough must be getting worse rather than considering that maybe, just maybe the patient has developed tolerance to the medication and is experienced experiencing early withdrawal symptoms that mimic the original complaint. This interpretation error was documented in medical journals of the era, written in dry academic language that completely missed the horrifying implications. Patient demonstrated increased therapeutic requirements over time, suggesting progressive disease pathology.

No, doctor, the patient is becoming addicted to your miracle cure. Those are different things. Some medical textbooks from the 1920s are genuinely painful to read, with the benefit of modern knowledge. They describe tolerance as if it's a feature of the patient's condition rather than a feature of the drug. They recommend gradually increasing doses to maintain therapeutic effect, which is technically the worst possible advice you could give someone taking opioids long term,

but they didn't know that. Or some of them knew, but were committed to their theories and unwilling to revise them based on inconvenient clinical observations. Medical science has always had a stubborn streak when it comes to abandoning cherished beliefs. There were some doctors who got it. To be fair, we should acknowledge them. By the early 1920s, a growing minority of physicians

were publishing papers and giving lectures about the addiction potential of heroin. They were documenting case studies of patients who'd started with therapeutic doses and ended up taking enormous amounts, who'd lost their jobs and families and health in pursuit of the drug. They were arguing for stricter controls,

for reconsidering heroin's availability, for developing alternative treatments. but they were fighting an uphill battle against institutional momentum, pharmaceutical company influence, and the general medical consensus that heroin was fine if used appropriately, whatever that meant. The concept of the blood-brain barrier itself was poorly understood in this era. Scientists knew there was some kind of selective permeability between the blood and the brain,

but the mechanisms weren't clear. The idea that you could design molecules to cross this barrier more effectively wasn't yet being systematically exploited, though it was happening accidentally. Biochemist had added those acetyl groups to morphine to create heroin, primarily to make it more potent and to see if they could patent a new formulation. The fact that this modification also made it cross the blood-brain barrier faster was an unintended bonus feature, like accidentally creating a sports car when you were just trying to make a regular car but prettier,

except this particular sports car was pointed at a cliff, and nobody had installed brakes. Let's talk about what doctors were actually observing in their patients, because this is where the gap between appearance and reality becomes almost comical if you ignore the human suffering involved. A patient starts heroin therapy for insomnia. For the first few weeks, they're a success story, sleeping eight hours a night,

reporting they haven't felt this rested in years, thanking the doctor profusely for his wisdom and modern medical insight. The doctor notes this in their file. Patient responding excellently to treatment. Continue current regimen. This is evidence-based medicine working exactly as intended, except it's actually the first chapter of a horror story that nobody realizes they're in yet. Month two, patient returns.

Still sleeping well, but they've noticed they need to take the medicine a bit earlier in the evening to get the same effect. Maybe increase the dose slightly, doctor agrees. This seems reasonable. Patients' condition clearly requires ongoing management. Dose is increased by 50%. patient leaves happy. Doctor notes. Adjusted therapeutic dose to maintain clinical efficacy. Patient tolerating medication well. Still looks like success from a short-term clinical perspective.

Month four, patient is taking triple the original dose. They're also taking it three times a day now morning, afternoon and evening, because they've discovered that taking it only at night leads to feeling terrible during the day. They don't mention this to the doctor because they're vaguely embarrassed about it, and also because they're getting their medicine from multiple pharmacies now, so there's no single medical professional tracking their total consumption. Doctor sees the patient during an appointment, notes they look tired and have lost weight, recommends they ensure adequate nutrition, and perhaps increase the evening dose further for better sleep quality. Patient agrees enthusiastically because that's exactly what they wanted to hear.

Doctor notes, patient experiencing continued sleep difficulties despite treatment, suggesting possible underlying depression or anxiety. Consider additional interventions. The actual problem severe opioid dependence goes undiagnosed. Month six, patient has lost their job due to performance issues. They're spending essentially all their money on heroin. They're experiencing constant withdrawal symptoms that they've managed to convince themselves are symptoms of some mysterious illness that the heroin is treating. They're trapped in a cycle where the medicine is causing the problem it's supposedly solving, and they can't see it because they're too close to the situation and too physically dependent to risk stopping.

The doctor, if they're still seeing them at all, has possibly started to suspect something is wrong, but may not have the conceptual framework to understand addiction as a medical condition rather than a moral failing. Medical education in this era included essentially zero training on addiction medicine. Doctors learned anatomy, physiology, pharmacology in the abstract, but not how to recognize or treat substance use disorder. orders. This pattern replicated across thousands of patients. The medical system was creating addicts at an industrial scale, while congratulating itself on providing effective therapeutic interventions. It's almost impressive in its systematic wrongness. Like, if you were trying to design a system

to maximize opioid addiction in a population, you could hardly do better than 1920s Paris, make the drug legal and easily accessible, have respected medical professionals recommend it, package it beautifully, create no barriers to access, provide no education about risks, misinterpret tolerance as therapeutic need, charge money so patients have to keep working to afford their habit, which delays the moment when they might hit bottom and seek help. It's a perfect storm of bad policy, incomplete science, and profit motive. Now let's examine the actual neuroscience that was happening, but that nobody fully understood. When heroin binds to mu-opioid receptors, it doesn't just produce pleasant effects.

It fundamentally alters how your brain processes reward and motivation. That dopamine surge we mentioned earlier, that's your brain's learning system being hijacked. Dopamine doesn't just make you feel good. It's a teaching signal that tells your brain this is important. Remember this. Do this again. Under normal circumstances, dopamine reinforces behaviours that help you survive, eating when hungry, drinking when thirsty, reproducing, socialising. These are all activities that produce dopamine release and thus get reinforced as important behaviours.

Heroin produces dopamine release that's far more intense than natural rewards. Your brain experiences this flood of dopamine and essentially concludes that heroin is the most important thing in the universe for your survival. This gets coded into your memory at a deep pre-conscious level. Cues associated with heroin use, the sight of the bottle, the ritual of taking the medicine, the location where you use it, Even thoughts about using all become powerful triggers that produce cravings. This is not a conscious choice or a failure of willpower. This is fundamental brain learning systems being hijacked by a chemical that exploits vulnerabilities in how our reward system evolved.

Your brain evolved over millions of years in an environment where the most intense rewards available were things like food, sex and social bonding. Natural selection never prepared your reward system for the possibility of synthetic chemicals that could produce reward signals 10 or 20 times more intense than anything available in the ancestral environment. It's like your brain's reward system is a lock that evolved to respond to particular keys, and heroin is a skeleton key that opens that lock far more effectively than anything natural. Once the lock has been opened with the skeleton key, regular keys seem inadequate.

Natural rewards, a good meal, a beautiful sunset, a conversation with a friend produced dopamine release that your brain now interprets as weak and unsatisfying compared to what heroin provided. This is why addiction is so difficult to overcome, you're not just fighting against physical withdrawal symptoms, though those are certainly terrible enough. You're fighting against your brain's fundamental learning and motivation systems, which have been reprogrammed to prioritize drug-seeking above essentially everything else. People in active addiction often engage in behaviours that seem completely irrational from the outside. They destroy relationships, lose jobs, experience serious health consequences, face legal problems, and yet continue using.

This looks like insanity or moral failure unless you understand that their brain's decision-making systems have been fundamentally altered. The part of their brain that evaluates is this worth it? Is giving the answer, yes, absolutely, this is the most important thing, even when objectively it very much is not. Doctors in the 1920s had essentially none of this neurochemical understanding. They knew drugs could be habit-forming that much was obvious from centuries of opium use, but they didn't understand the mechanisms. They didn't know about dopamine.

The concept of the mesolimbic reward pathway wouldn't be elucidated until decades later. They were trying to understand addiction with roughly the same level of neurological knowledge that medieval physicians had when they attributed disease to imbalances in the four humors. They were making observations and drawing conclusions, but their theoretical framework was so incomplete that most of their conclusions, conclusions were wrong, or at best severely limited. Some doctors hypothesised that addiction was a matter of personality or moral character. The theory went that strong-willed people with good moral foundations wouldn't become addicted because they'd have the self-control to stop using

before dependence developed. This is a comforting theory if you're a doctor prescribing heroin, because it means any addiction that develops is the patient's fault, not yours. It also happens to be completely wrong. Addiction doesn't discriminate based on moral character. Give any human being sufficient exposure to heroin, and they will develop physical dependence. This is simple biology. Individual variation exists. Some people are more susceptible than others due to genetic factors, previous trauma, co-occurring mental health conditions, but nobody has some special immunity based on being a good person. That's not how brain chemistry works. Other doctors attributed addiction to the underlying condition being treated. If someone

became dependent on heroin they were taking for pain. The explanation was that they had a pain condition that required ongoing medication, not that the heroin itself was the problem. This created a tautological trap. The medicine is necessary because stopping it causes terrible symptoms, and the symptoms prove the medicine is necessary. This is perfect circular logic that's completely wrong, but very difficult to escape once you're caught in it. There were attempts at studying heroin systematically. Medical journals published papers on its clinical applications, its efficacy for various conditions, optimal dosing regimens. Reading these papers today is an exercise in dramatic irony. You can see the addiction developing in the data, but the authors interpret it as something else.

Patients demonstrated need for increasing doses over extended treatment periods sounds like a neutral clinical observation until you realize it's describing tolerance and escalating dependence. High patient compliance and satisfaction with treatment sounds positive until you understand that, of course, patients are satisfied, they're addicted, and you're providing them with the substance they're dependent on. They're not satisfied. They're dependent. Those are different things. Some studies noted that patients became difficult to withdraw from therapy or showed resistance to treatment discontinuation. Again, this sounds like medical jargon describing some neutral phenomenon, but it's actually describing people who are physically addicted and terrified of withdrawal. the language obscures rather than illuminates the reality of what's happening. This is a persistent problem in medicine, then and now the tendency to use technical terminology that creates distance from the human reality of suffering. The patient experienced adverse outcomes is a very different sentence emotionally than we accidentally got someone hooked on heroin and now their life is falling apart,

even though they might be describing the same situation. Let's look at a specific example of how medical thinking is. went wrong, there was a French physician, we'll call him doctor. Bernard Lefev, though I'm making up that name because I don't want to single out any specific historical individual for ridicule who published a paper in 1923, arguing that heroin was an ideal long-term treatment for what he called neurasthenic syndrome. Neuristhenia was a fashionable diagnosis at the time, basically a catch-all for anxiety, depression, fatigue and vague complaints of modern life being exhausting. Dr. LaFerve had been prescribing heroin to neurasthenic patients for five years and reported excellent results.

His patients felt better, their symptoms improved, they were able to function in daily life. He documented all of this carefully with detailed case notes and follow-up appointments. What Dr. Lefev failed to notice, or perhaps notice but misinterpreted, was that every single one of his long-term heroin patients had increased their dose substantially over the treatment period. he also didn't notice was that several had started obtaining additional supplies from other sources. What he definitely didn't recognise was that when he tried to taper or discontinue treatment in a few patients who claimed they were feeling better, they experienced such severe anxiety and discomfort that treatment had to be resumed at higher doses than before. His interpretation, their neurasthenia was more severe than he initially diagnosed and they required ongoing pharmaceutical

support. The alternative interpretation that he'd created severe opioid dependence that mimicked and exacerbated the original anxiety condition apparently didn't occur to him, or if it did, he dismissed it as unlikely. Dr. Lefev's paper was influential. Other physicians read it and thought, Yes, excellent. This confirms that heroin is appropriate for long-term use in nervous conditions. They adopted similar prescribing practices. Medical conferences featured present. on the benefits of opioid therapy for various psychiatric conditions. Textbooks included heroin among recommended treatments for anxiety and depression. The medical establishment was building a consensus around heroin's safety and efficacy,

and this consensus was based on clinical observations that were systematically misinterpreted due to incomplete understanding of addiction neurobiology. There's a particular irony in how doctors understood heroin's mechanism of action. They knew it was an opioid, derived from more, which came from opium, which came from poppies. They knew it affected the nervous system, producing analgesia and sedation. They even knew it acted on specific receptors in the brain, though they didn't understand these receptors in any detail. What they thought was happening was something like heroin binds to pain receptors, blocks pain signals, patient feels better,

treatment successful. This is not entirely wrong heroin does block pain signals, but it's catastrophically incomplete. They missed the adaptation. They missed the tolerance. They missed the way the brain's reward system gets hijacked. They missed the distinction between acute effects and chronic effects. They saw short-term improvement and extrapolated that long-term use would produce continued improvement, which is roughly like observing that jumping off a building produces an exhilarating feeling of flight, and concluding that it's an excellent long-term transportation strategy. The initial phase is great. It's the landing that presents problems. Some of the more honest medical writing from this period acknowledges

uncertainty. You find phrases like, the long-term effects require further study, or clinical experience suggests generally favourable outcomes, though some patients present complications. This is scientific caution, which is admirable, but it was being deployed to justify continued widespread use of a substance that was actively ruining thousands of lives. At some point, we need more data becomes an excuse for inaction when the data you already have strongly suggests a serious problem. The pharmacy pharmaceutical company is naturally funded research that supported their products. This wasn't necessarily sinister conspiracy, though it certainly wasn't neutral scientific inquiry either. When a company pays for a study on its product, there's enormous pressure, both explicit

and implicit, for that study to produce favourable results. Researchers whose studies show problems might not get funding for future work. Papers that highlight concerns might have difficulty getting published if the pharmaceutical company has influence over medical journals, which many did through advertising revenue and other financial relationships. The deck was stacked toward producing evidence that heroin was safe and effective, and lo and behold, much of the published research concluded exactly that. Independent researchers who raised concerns found themselves marginalized. There were physicians and scientists who, by the early 1920s, were arguing loudly that heroin was causing massive public health problems. They presented.

presented cases of severe addiction, documented the progression from therapeutic use to dependence, proposed that heroin should be strictly controlled or banned entirely. They were dismissed as alarmists or moralists trying to impose their values on medical practice. The mainstream medical establishment, heavily influenced by pharmaceutical money and committed to their existing practices, was not interested in hearing that their miracle drug was actually a disaster. This dynamic should sound familiar to anyone paying attention to more recent pharmaceutical controversies, The opioid epidemic of the late 20th and early 21st centuries followed a remarkably similar pattern. Pharmaceutical companies claimed their new opioid formulations were safe for long-term use,

not significantly addictive if used as prescribed. Doctors believed them and prescribed accordingly. Patients became addicted in enormous numbers. Independent researchers raised alarms. They were ignored until the problem became too large to ignore. History doesn't repeat itself, but it certainly rhymes. usually in ways that suggest humanity is not particularly good at learning from past mistakes. Back to the neuroscience.

One aspect that particularly confused doctors was the phenomenon of withdrawal. When patients stopped taking heroin, they became incredibly sick. Sweating, shaking, vomiting, experiencing severe anxiety and dysphoria, unable to sleep, bones and muscles aching like they were being twisted from inside. This looked like illness. Therefore, doctors reasoned, the heroin. must have been treating some underlying illness, and stopping the medicine allowed the illness to return in force. This interpretation made sense given their framework, but was exactly backwards.

The illness was withdrawal from the drug itself. The medicine had created the problem. To understand why withdrawal feels so terrible, we need to understand opponent process theory, though this theory wouldn't be formally articulated until decades after our story takes place. The basic idea is that the brain maintains emotional and physiological balance through a processes. When something pushes you in one direction, say, a drug produces euphoria and relaxation. Your brain activates opposing processes that push in the other direction, dysphoria and agitation, to maintain equilibrium. During active drug use, the drugs effects overpower these opponent processes so you feel the net positive effects. But if you stop taking the drug, the opponent processes

are still active, now without anything to counterbalance them, so you experience a rebound in the opposite direction. This is why heroin withdrawal produces symptoms that are essentially the opposite of heroin's effects. Heroin produces constipation. Withdrawal produces diarrhea. Heroin produces relaxation. Withdrawal produces agitation. Heroin suppresses pain. Withdrawl amplifies pain sensitivity. Heroin produces calm. Withdrawl produces anxiety. Your brain has tuned its opponent processes to counteract heroin's effects, and suddenly heroin is gone, but the opponent processes remain, at least until your brain can slowly readjust to the new normal. This takes time, days for acute physical symptoms, weeks to months

for psychological symptoms, sometimes years for certain brain functions to fully normalise. Doctors in the 1920s observed these withdrawal symptoms and interpreted them as evidence that patients needed the medicine. A few doctors experimented with gradual tapering, reducing doses slowly to ease the transition, which is actually the correct approach. But even gradual tapering is extremely difficult with short-acting opioids like heroin. The drug leaves your system quickly. Withdrawal symptoms emerge within hours of the last dose, and the temptation to just take more medicine and make the discomfort stop is overwhelming. Successful withdrawal really requires medical supervision, supportive care, possibly other medications to ease symptoms, and a structured environment

where the person can't access heroin, even if they desperately want to. None of this infrastructure existed in 1920s Paris. You were essentially on your own, trying to quit through sheer willpower while feeling worse than you'd ever felt in your life, and with easy access to the substance that would instantly make you feel better. The failure rate was approximately 100%. Let's talk about the concept of therapeutic window, because this is where medical thinking in the 1920s really demonstrates its limitations. Every drug has a therapeutic window, the range of doses between, not enough to work and too much causing harmful effects. For most medications, this window is

reasonably wide and stays consistent over time. Take aspirin. The dose that relieves your headache today will probably still relieve your headache next month. Your body doesn't adapt to aspirin in a way that requires constantly increasing doses. Heroin's therapeutic window, if it can even be said to have one, is extraordinarily narrow and constantly shrinking due to tolerance. The dose that effectively treats your cough today will be insufficient next week. The dose that treats your anxiety this month will barely touch it next month. And as your dose escalates, you're getting closer and closer to doses that produce serious side effects, respiratory depression, severe constipation, cognitive impairment, and eventually overdose.

The gap between enough to prevent withdrawal and enough to kill you get smaller as tolerance develops. You're climbing a ladder where the rungs keep getting narrower and eventually they run out and there's just a sheer wall leading to a very unpleasant fall. Doctors didn't fully grasp this dynamic. They understood that some patients needed increasing doses, but they didn't understand that this was an inevitable consequence of the drug's effects on the brain, not a feature of the disease being treated. They didn't understand that they were prescribing patients onto a trajectory that had no good outcomes.

Either the patient would continue escalating doses until they overdosed, or they'd run out of money and access and be forced into withdrawal, or they'd somehow managed to quit and spend months or years recovering. There was no happy ending where someone takes heroin daily for years and then effortlessly stops when they decide they don't need it anymore. That's not how opioid pharmacology works. Some patients figured this out on their own. They realized they were trapped.

They tried to communicate this to their doctors. I think I'm becoming dependent on this medicine. And you know what many doctors told them? That it was psychological, not physical, that they just needed to be strong. that the medicine wasn't truly addictive if used properly, that their difficulties were a reflection of their underlying condition or their personal weakness, not the drug's properties. This was medical gaslighting, though they didn't call it that.

Patients were experiencing a real, severe, physically based addiction, and medical authorities were telling them it was all in their head. There were a few exceptional doctors who understood what was happening and tried to help. They developed early detoxification protocols, They advocated for patients, they published warnings in medical journals, but they were swimming against a powerful current of institutional inertia, pharmaceutical money, and cultural attitudes that valorized pharmaceutical solutions and stigmatized addiction. The dominant narrative was that modern medicine had conquered pain and suffering through chemistry,

and anyone who suggested this triumph might have downsides was being a Luddite or a moralist or both. The concept that eventually emerged that addiction is a chronic brain disease, requiring long-term treatment and support, was still decades away from mainstream acceptance. In the 1920s, addiction was viewed as either a moral failing or a temporary problem that could be solved through willpower and short-term medical intervention. The idea that someone might need years of support, therapy, community resources,

and possibly medication-assisted treatment to maintain recovery would have seemed absurd to most doctors of this era. They had a mechanistic view. Problem arises, apply chemical solution, problem resolved. The notion that the chemical solution might create its own chronic problems that required complex, multifaceted, long-term interventions didn't fit their framework. Let's examine what happens in the brain during chronic heroin use, because this is where the science gets genuinely fascinating if you can ignore the human suffering it describes. Your brain doesn't just adapt to heroin

at the receptor level. It adapts structurally. Brain imaging studies, done decades later, show that Chronic opioid use changes the physical structure of the brain. Areas involved in decision-making, impulse control and emotional regulation show altered development. The prefrontal cortex, your brain's executive control center, becomes less active. Areas involved in habit formation and automatic behavior become more active. Your brain is literally rewiring itself to prioritize drug-seeking behavior over other goals. These changes persist long after someone stops using. This is why addiction is a chronic condition.

condition. Even after months or years of abstinence, the brain changes remain. Someone in long-term recovery can still experience cravings triggered by cues associated with their previous drug use. Their decision-making abilities may remain impaired. Their emotional regulation might be difficult. The brain can heal. Neuropasticity is real, and recovery is absolutely possible, but it takes time, often years, and the brain never quite returns to its pre-addiction state. You can't unring that bell completely. None of this was visible to doctors in the 1920s. They couldn't do brain scans. They couldn't measure neurotransmitter levels. They couldn't see the structural changes happening in their patient's brains. They were working blind, making educated guesses based on external

behaviour and patient reports, and getting it wrong more often than right. This isn't entirely their fault. They were limited by the scientific knowledge and technology available at the time, but it's also not entirely excusable because enough evidence existed to suggest serious problems and that evidence was largely ignored or misinterpreted because acknowledging it would have been inconvenient. The reports that doctors filed and the textbooks they wrote paint a picture of confident competence that was completely unwarranted. They wrote with authority about optimal dosing regimens, about which patients were good candidates for heroin therapy about managing side effects.

They presented their clinical experience, as evidence of heroin safety and efficacy. And all of this confidence was based on a fundamental misunderstanding of what was actually happening in their patient's brains. They were mistaking addiction for effective treatment. They were mistaking tolerance for disease progression. They were mistaking withdrawal for the underlying condition. It's actually impressive how consistently they got things backwards. There's a lesson here about the dangers of overconfidence in medicine, about the importance of long-term follow-up and systematic study, about how financial incentives can warp scientific conclusions about the need for humility in the face of complex phenomena we don't fully

understand. But historically speaking, these lessons were not learned in the 1920s. They would be painfully relearned multiple times over the subsequent century, each time with a new drug or treatment that seemed miraculous until the long-term consequences became too obvious to ignore. Medicine advances, but slowly, and often only after considerable human suffering, has provided the data that retrospective analysis would have preferred to avoid. Now, we need to talk about how pharmaceutical companies convinced an entire medical establishment that prescribing heroin to basically everyone was not just acceptable, but actually progressive, modern, and scientifically sound.

Because doctors didn't just wake up one morning and decide to hand out opioids like candy at a parade. They were systematically educated, persuaded, and equipped with marketing materials disguised as medical literature. This was corporate influence operating at peak efficiency, and it worked so well that similar playbooks would be dusted off and reused throughout the 20th century whenever a pharmaceutical company needed to convince doctors that their potentially dangerous product was actually perfectly safe.

Let's start with the medical journals, because these were the cornerstone of pharmaceutical marketing in an era before television ads and internet pop-ups. Medical journals in the 1920s were ostensibly scientific publications dedicated to advancing medical knowledge, and they did contain legitimate research, case studies, and theoretical discussions. They also contained advertisements, lots of advertisements, sometimes the ads outnumbered the actual articles,

which should tell you something about the journal's funding model. Pharmaceutical companies were major advertisers, and they weren't just buying ad space, they were buying influence over the entire publications editorial direction, though nobody would have admitted this at the time. The advertisements themselves were masterpieces of persuasions. design, full-page spreads featuring elegant illustrations, authoritative text, and carefully chosen testimonials from respected physicians. A typical ad might show a refined woman, always well-dressed,

always white, always looking slightly melancholic in that fashionable 1920's way, with text explaining how heroin preparations had restored her ability to function after nervous exhaustion. Or it might show a doctor in his office, looking wise and caring, with text describing how he'd helped dozens of patients overcome chronic cough with this remarkable medicine. The visual language was all about respectability, science, caring, progress, nothing that suggested danger or addiction or ruined lives, just healing and modernity and the triumph of pharmaceutical chemistry over human suffering. The copy in these ads was carefully crafted to sound scientific,

while making bold claims that wouldn't pass regulatory scrutiny today. Provides rapid relief from persistent cough, without the complications associated with traditional morphine preparations. This sounds neutral and factual. It's actually saying heroin works faster and better than morphine, which is true, but it's leaving out because it crosses the blood-brain barrier more efficiently, which also makes it more addictive.

The art of pharmaceutical advertising has always been about what you don't say as much as what you do say. Some ads included what appeared to be excerpts from medical research. A study of 200 patients demonstrated significant, significant improvement in sleep quality and anxiety reduction with minimal side effects. These weren't fabricated exactly. There usually was some study behind the claim, but the presentation was selective. They'd highlight the short-term positive results and minimize or completely omit the long-term consequences. They'd mention that patients showed continued therapeutic

requirements without explaining that this was code for became addicted and needed escalating doses. The language was technically accurate but fundamentally misleading, which is the gold standard of pharmaceutical marketing. Beyond the ads, pharmaceutical companies sponsored research and ensured that favorable results got published prominently. This wasn't necessarily a sinister conspiracy. Companies funding research into their own products is normal and even necessary to some degree. But it creates massive bias. Researchers who produce unfavorable results don't get continued funding. papers that highlight problems get quietly buried. Studies are designed in ways that maximize the chance of positive results, short duration trials that don't capture long-term addiction,

patient selection that excludes people most likely to have problems, outcome measures that focus on symptom relief rather than overall quality of life. The result is a body of published literature that creates an illusion of safety and efficacy while systematically hiding the downsides. Medical conferences were another crucial marketing venue. Pharmaceutical companies didn't just sponsor these conferences financially. They shaped the agenda. They funded speakers who would present favourable research. They hosted elaborate booths in exhibition halls,

where they'd distribute literature and samples. They threw parties and dinners for prominent physicians, building relationships that would influence prescribing behaviour. A doctor who'd been whined and dined by pharmaceutical representatives who'd attended presentations showing how effective heroin was for nervous conditions, who'd been given free samples to try with their patients. That doctor was significantly more likely to start prescribing the company's products. The pharmaceutical representatives themselves,

the specialists in introduction, as they were sometimes called, which is possibly the most dystopian job title imaginable, were a fascinating phenomenon. These were not medical professionals, though they dressed and spoke with medical authority. They were salespeople, but they didn't present themselves that way. They'd visit doctor's offices with briefcases full of literature and samples,

positioning themselves as educators providing valuable information about the latest therapeutic advances. Doctor, I wanted to make you aware of recent clinical findings regarding opioid therapy for anxiety disorders. We've seen remarkable results. Perhaps you'd like to try some samples with appropriate patients. This wasn't a sales pitch in their presentation. It was collegial information sharing between professionals. except one of those professionals was being paid commission on sales volume. These representatives were trained extensively in pharmaceutical properties,

medical terminology, and persuasion techniques. They could speak fluently about pharmacokinetics and therapeutic windows and clinical protocols. They could answer doctors questions with apparent expertise. They were essentially actors playing the role of medical consultants, and they were very good at it. Doctors, who were busy and often genuinely trying to help their patients, trusted these representatives as sources of reliable information. After all, they seemed knowledgeable. They were associated with respected pharmaceutical companies, and they weren't obviously trying to deceive anyone.

The deception was structural, built into the system itself, not necessarily conscious fraud by individuals. The free samples were particularly insidious. A pharmaceutical representative would leave a doctor with dozens of small bottles of heroin syrup or boxes of tablets. Try these with your patients who present with these. insomnia or nervous complaints, I think you'll find the results impressive. The doctor, who now had free medicine to offer patients, would naturally try it. Patients would report excellent results, because heroin does work remarkably well initially. The doctor would be impressed and would start prescribing the medication, which meant writing prescriptions that patients would fill at pharmacies, which meant sales for the pharmaceutical company. The free samples were an investment that paid

substantial returns, this same strategy is still used today with various medications because it's staggeringly effective at shaping prescribing behaviour. Let's talk about the slogans and messaging that pharmaceutical companies used, because these are genuinely remarkable for their ability to reshape how people thought about mental health and normalcy. One company marketed their heroin preparation with the tagline, Restore Natural Sleep. This is brilliant manipulation. It positions heroin use as returning something to its natural state, rather than introducing a powerful foreign chemical. It suggests that insomnia is unnatural, and heroin is correcting this abnormality, when actually the reverse is true. Your natural state involves some difficulties sleeping

occasionally, and heroin is the abnormal intrusion. Another popular angle was, Modern Relief for Modern Alments. This positioned heroin as the solution specifically designed for the stresses of 20th century life. The implicit message was that previous generations didn't need these medications because they lived simpler lives, but modern existence with its urban density, industrial pace, social complexity, created new forms of suffering that required new pharmaceutical solutions. This is appealing because it validates people's feelings that modern life is uniquely stressful while offering a simple answer. Take this medicine and you'll be equipped to handle modernity. The fact that this medicine would

eventually destroy your ability to handle anything went unmentioned. Some marketing materials explicitly reframed normal human experiences as medical problems requiring treatment, feeling anxious before a big presentation. That's not normal nervousness. That's pathological anxiety that should be medicated. Having trouble sleeping because you're worried about money, that's not situational stress that's chronic insomnia requiring pharmaceutical intervention. The pharmaceutical industry was actively medicalising ordinary human experiences, expanding the definition of illness to include more and more normal life, because the more things that count as medical problems, the more products they can sell to fix them. This phenomenon has accelerated dramatically in

modern times, but it started in earnest in the early 20th century, with the rise of industrial pharmaceutical manufacturing. Companies realised they could create demand by convincing people they had problems they didn't know they had. You weren't just tired. You had neurasthenia. You weren't just occasionally sad. You had melancholia requiring treatment. You weren't experiencing normal human emotion. You were suffering from a deficiency of pharmaceutical products,

buy our medicine and become normal again. Except normal had been redefined to mean constantly medicated, and nobody seemed to notice the shift. Educational campaigns targeted at physicians were particularly sophisticated. Pharmaceutical companies would produce what looked like neutral educational materials, pamphlets, reference guides, dosing charts that doctors could use in their practice. These materials were beautifully designed and seemingly objective, but they were fundamentally marketing tools,

they'd emphasize heroin's benefits, minimize its risks, and subtly encourage liberal prescribing. A dosing chart might suggest starting doses that were actually quite high, or might recommend dose escalation after just a few days, or might list an extensive range of appropriate conditions. Doctors using these materials as reference guides were essentially following a marketing playbook disguised as clinical guidance. Some pharmaceutical companies went further and offered to train doctors directly. They'd host workshops or seminars where physicians could learn about the latest therapeutic approaches,

which conveniently emphasised the company's products. These weren't advertised as marketing events. They were framed as continuing medical education, which is something doctors need and value. But the content was shaped entirely by commercial interests. Attendees would leave these events convinced that heroin was an appropriate first-line treatment for a wide range of conditions, and they'd start prescribing accordingly, which was exactly the outcome the pharmaceutical company had paid to achieve. The pharmaceutical companies also cultivated relationships with prominent physicians and researchers, essentially creating key opinion

leaders who would advocate for their products. These weren't necessarily corrupt arrangements, though some probably were, but rather a sophisticated understanding that if you can convince the most respected doctors to endorse your product, everyone else will follow. So companies would fund research by prominent physicians, invite them to speak at conferences, cite their work in marketing materials, and generally elevate their status in the medical community. These physicians would then, quite genuinely believing they were advancing medical science, advocate for the company's products. Their endorsement carried enormous weight because they were trusted authorities, not obvious shills. The fact that they were,

research and speaking fees came from the pharmaceutical company, created conflicts of interest that were rarely disclosed and apparently rarely considered problematic. Let's shift now from the corporate boardrooms and medical conferences to the cobblestone streets of Monmart, because this is where heroine's influence on culture becomes visible in ways that are both fascinating and deeply sad. Monmart in the 1920s was the artistic heart of Paris, a neighbourhood of studios and cafes and galleries, where the avant-garde gathered to create the future of art, literature and thought. It was bohemian in the original sense, unconventional, artistic, often poor but always interesting. This was where you'd find painters developing cubism and surrealism,

writers experimenting with stream of consciousness and automatic writing, musicians exploring jazz and attenality. It was electric with creative energy and possibility. It was also quietly filling with heroin users, though nobody called it. called them that. They were artists managing their nerves, writers treating their insomnia, musicians addressing their anxiety. The language was always therapeutic, always medical, always legitimate. But the effect was the same, a growing population of creative individuals whose consciousness was being chemically altered on a daily basis, and whose creative output was increasingly shaped by opioid use. The artistic studios of Monmarch became something like

quiet laboratories for observing what happens when you give creative people unlimited access to heroin. The initial effects seemed positive. Artists reported enhanced sensitivity to color and form. Writers felt that their prose flowed more easily, that they could access deeper emotional truths. Musicians found that heroin quieted the critical voice in their head and allowed them to perform without crippling stage fright. These were real effects. Opioids do reduce anxiety and can create a sense that your creative work is profound and important. The problem, of course, is that this sense is often delusional. The work created under the influence frequently isn't as good as the artist believes it to be,

and more importantly, the ability to create at all gradually deteriorates as addiction progresses. Let's follow a typical trajectory. We'll call him Antoine, a painter living in a cramped studio on Rue Lapeake. He's 26, moderately talented, extremely ambitious, and constantly anxious that he's not producing work of sufficient importance fast enough. If fellow artist mentions that he's been taking this marvellous medicine for nerves, helps him focus, makes the work flow, Antoine tries it. The first time he paints, while under heroine's influence, it's revelatory.

The colours seem more vibrant, the brushstrokes feel more confident, the usual paralysing self-doubt that makes him second-guess every decision is simply absent. He paints for six hours straight, completely, absorbed in the work, and when he steps back to look at the canvas, he's convinced he's just created his masterpiece. The next morning, looking at the same canvas sober, he has doubts. It's not bad, but is it really as brilliant as it seemed last night? Hard to say, but the experience of creating it was so positive, so free of the usual anxiety and frustration, that he decides to try painting under the influence again, and again. Within a few weeks, he's taking heroin every time

he works. The medicine has become part of his creative process as essential as brushes and canvas. Here's where it gets problematic. As tolerance develops, Antoine needs higher doses to achieve the same effects, but higher doses don't just quiet anxiety. They produce sedation, cognitive dulling, motor impairment. His brushwork becomes less precise. His color choices become muddy and confused. His ability to sustain focus on complex compositional problems deteriorates. He's still painting, but the quality is declining even as he's becoming more convinced of his own genius. A common effect of opioid intoxication is inflated self-assessment combined with actual declining performance. Eventually, he's not really painting at all anymore. He's sitting in his studio,

nodding off, maybe making a few desultry brushstrokes per day, but mostly just maintaining his habit and trying to stave off withdrawal. The creative dreams that brought him to Paris are replaced by the singular goal of acquiring and consuming more heroin. His studio, which was supposed to be a space of artistic creation, has become just another place to get high. This same pattern replicated across dozens, probably hundreds of artists in Monmart during this period. The cafes and salons tell a similar story. These were supposed to be spaces of intellectual ferment, where artists and writers would gather to debate aesthetic theories, share work, argue about the direction of modern art. and they were that initially.

But gradually, the character of these gatherings changed. Conversations that used to be sharp and engaged became languid and unfocused. Debates that used to generate heat and insight devolved into agreeable nodding. People would sit for hours saying very little, lost in private reveries induced by the medicine they'd taken before arriving. The salons became less about creative exchange and more about communal sedation. Some participants describe this as enhanced censors. sensitivity, a deeper, quieter form of artistic engagement. They convinced themselves that this dreamy passivity was actually a higher state of consciousness, more authentic and profound than normal waking

awareness. This is a common rationalisation among drug users, particularly those in artistic communities. The drug's effects get reframed as aesthetic or spiritual enhancement rather than intoxication. I'm not high, I'm accessing deeper creative truths. Sure, and the inability to finish a sentence or focus on a conversation for more than 30 seconds is because you're operating on some elevated plane of consciousness, not because you're significantly impaired by opioids. This kind of self-deception is part of addiction's architecture. What's particularly tragic is that these artists often had genuine talent. They came to Paris with real gifts, real potential to contribute something meaningful to art

and culture, and that potential got systematically destroyed by a drug that was sold to them as medicine for the normal anxieties that accompany creative work. They didn't sign up for addiction. They signed up for treating their insomnia or nervousness. They thought they were being responsible and modern by using pharmaceutical tools to manage their mental health. They had no idea they were walking into a trap that would consume years of their lives and most of their creative potential. Some studios in Monmart developed reputations as places where you could acquire heroin more easily than through normal pharmacy channels. These weren't traditional drug dealers in the modern sense, they were artists who'd accumulated supplies and were willing to share or

sell to friends. But functionally, they were operating as small-scale distributors. A studio would become known as a place where you could stop by if you were running low and needed something to get through the night. The artist living there would have extra bottles or tablets available, acquired from multiple pharmacies, and would sell them at a modest markup. This was presented as helping out fellow artists, maintaining the creative community, ensuring everyone had access to the medicine they needed to work. It was actually drug dealing, but nobody wanted to use that terminology because it sounded criminal rather than bohemian. These artist dealers, or pharmaceuticals of inspiration, as they sometimes styled themselves with considerable pretension, played a crucial

role in expanding heroines' reach through Montmart. They were trusted community members, not sketchy criminals. Buying from them felt safe and socially acceptable. They'd chat about art and literature while selling you the drugs, maintaining the illusion that this was all sophisticated and intellectual rather than desperate and destructive. Some of them genuinely believe they were performing a service. Others were probably aware they were feeding others' addictions, but rationalised it because they were addicted themselves and needed the money to maintain their own supply. The economics of this small-scale dealing are worth examining. Heroin was still relatively inexpensive when purchased through legitimate pharmacy channels, but as someone's habit grew, the

costs accumulated quickly. If you could buy in bulk, say, 20 bottles at once instead of one, and then sell half at a slight markup, you could effectively get your own supply for free or even at a profit. This created incentive structures that encouraged users to become dealers. The progression was almost natural. Start as a user, develop a habit that's expensive to maintain, realize you can offset cost by selling to others, gradually transition from user who deals to dealer who uses. Many of Monmart's artist dealers followed exactly this path. The studios where dealing happened often became strange hybrid spaces, part art studio, part salon, part pharmacy, part shooting gallery, though that last term wouldn't become common until later when injection became the

predominant route of administration. People would stop by ostensibly to view artwork or discuss aesthetics, and while they were there, they'd quietly acquire their medicine. The host would maintain the fiction that this was primarily a creative space, that the drug transactions were incidental to the real purpose of artistic exchange, but increasingly the drugs were the point, and the art was the cover story. What's particularly interesting is how this underground economy remained underground, despite being fairly open. Police occasionally raided studios, but enforcement was inconsistent and half-hearted. Artistic communities had a certain level of social protection. They were seen as eccentric but not truly dangerous, creative rather than criminal. The authorities seemed willing to

tolerate a fair amount of drug use among artists, perhaps because artists weren't seen as serious people whose behavior needed strict regulation. This created a bubble of relative safety where heroin use could flourish without immediate legal consequences, which allowed the problem to grow much larger before authorities finally decided it needed to be addressed more aggressively. Looking to see what's happening around your home? Rings, battery doorbells? helps you track packages and see who's at your door in real time. The outdoor cam plus protects your yard at night with a wide field of view and clearer retinal 2K video. Or upgrade to 4K cameras and doorbells with retinal vision for ultra clear zoom in detail.

Your door, your yard, your home. With Ring, it's protected. Shop cameras, doorbells, and more at ring.com now. I wrote a little song to remind you, choice hotels, get you more of the experiences you value. The can be a hotel's got it all. A rooftop bar, have a ball Bring a date, your squad or even your mom Book direct at choiceotails.com

The book's salons and literary gatherings followed similar patterns. These were supposedly intellectual spaces dedicated to literature and ideas, and they were that, but they were also spaces where heroin use became normalized and even romanticized. Writers would gather to read their work,

discuss the latest publications, argue about literary movements, and many of them would be significant. impaired by opioids while doing so. The quality of discussion suffered accordingly. What was supposed to be sharp literary criticism became meandering and unfocused. Readings that should have been engaging became soporific, literally, as both readers and listeners were often sedated. Some literary figures explicitly connected heroin use to their artistic practice. They'd claim that opioids gave them access to different states of consciousness that enrich their writing. They'd cite

precedence to Quincy's confessions of an English opium eater, Coleridge's alleged opium-fuelled composition of Kubla Khan, has evidence that opioid use and literary creation were compatible or even synergistic. What they failed to note was that these earlier examples were of occasional use followed by vivid writing about the experience, not daily addiction followed by declining output. But addiction has a way of making people cherry-pick historical examples that support their continued use, while ignoring all the evidence suggesting it's a terrible idea. The transformation of these cultural spaces from vibrant creative environments to quiet chambers of shared sedation is one of the sadder aspects of this story. Mon Marta should have been

experiencing a golden age of artistic innovation in the 1920s, and it was, to some degree, but its full potential was being systematically undermined by widespread opioid use. How many masterpieces went unwritten because the potential author was too impaired to work? How many artistic movements failed to develop because the people who might have driven them forward were struggling with addiction? How many cafes that could have hosted world-changing conversations instead hosted semi-conscious people nodding off into their coffee? We can't quantify these losses, but they were real. There's a particular irony in how heroin was marketed as a medicine that would help people function better while simultaneously destroying the ability to function

in any meaningful way. The pharmaceutical company, companies promised that their products would restore normal life, and what they actually delivered was a chemical dependency that made normal life impossible. Artists thought they were acquiring tools to enhance their creativity, and what they actually got was an addiction that consumed their creative drive. The gap between promise and reality was enormous, but the marketing was so effective that people kept believing the promises long after reality had thoroughly disproven them. The impact on productivity was dramatic, but gradual enough, that it was easy to miss or misattribute. An artist who used to complete a major work every few months found himself

taking longer and longer to finish pieces, six months, nine months, a year. Eventually not finishing at all, just endlessly revising and reworking because the critical faculties necessary to declare something finished were impaired. A writer who used to produce regular output found her productivity declining. Fewer stories finished, longer gaps between publications, eventually nothing at all, just endless notes and fragments that never co-heared into complete work. This looked like creative block or revolving standards or the natural ebb and flow of artistic production. It was actually addiction progressively destroying cognitive function and motivation. The social dynamics within artistic communities also shifted in response to widespread heroin use.

These communities had always been somewhat tight-knit artists supporting each other, sharing resources, maintaining solidarity against the mainstream culture that often didn't appreciate their work. But heroin created new fault lines and alliance structures. People who used became closer to other users, forming bonds based on shared drug connections rather than shared artistic interests. People who didn't use, or who recognised that drug use was becoming problematic, found themselves marginalized or pushed out of social circles that had previously welcomed them. The drug became more important than the art in determining who belonged and who didn't. Some of the more perceptive observers within these communities recognized what was happening and tried to raise alarms. There were artists and

writers who saw their friends and colleagues descending into addiction and tried to intervene, tried to convince people to stop, tried to organize some kind of collective response to what was clearly becoming a community-wide crisis. These efforts rarely succeeded. Addiction is a powerful force and artistic community's cultural emphasis on individual freedom and resistance to authority made collective action difficult. Warning someone that their drug use was destroying their talent sounded like bourgeois moralising, not genuine concern. Suggesting that maybe the whole community should stop using heroines sounded like conformity and censorship, not health and safety. The cultural values that made artistic communities vibrant and creative also made them vulnerable to collective self-destruction

when a dangerous substance became normalized. By the mid-1920s, certain studios and cafes in Monmart had reputations as heroin hotspots. Everyone knew which establishments tolerated or even facilitated drug use. These became destinations for people seeking drugs, which changed their character entirely. What had been organic creative communities became something more like modern drug scenes,

places defined primarily by the presence of drugs rather than by artistic activity. New arrival. to these spaces came not because they were artists seeking creative fellowship, but because they were users seeking drugs and community with other users. The original artistic purpose got buried under the drug culture. This transformation wasn't unique to Paris or to the 1920s. Similar patterns have repeated in various cultural contexts whenever drugs become prevalent in creative communities. The beatnik scene in the 1950s, the hippie communes in the 1960s, the punk scene in the 1970s, the

brave culture in the 1990s. Each time, drug use gets romanticised as part of the countercultural identity. Each time, some genuinely talented people, produce interesting work despite or occasionally inspired by their drug use, and these examples get held up as evidence that drugs and creativity go together. Each time, many more people destroy their talent and potential through addiction. But these casualties are less visible, less talked about, not part of the cultural narrative. The mythology persists because humans love the story of the brilliant artist, who creates masterpieces while high, and we're less interested in the much more common story of the talented person who might have created something meaningful, but instead spent their productive years trapped in addiction.

The pharmaceutical companies naturally bore no responsibility for any of this in their own minds. They were selling medicine through legitimate channels. If some people misused their products, that was a matter of individual choice and perhaps weak moral character. If artistic communities developed drug problems, that was the artist's fault for being undisciplined and self-indulgent. The companies certainly weren't going to examine whether their aggressive marketing and their deliberate efforts to expand heroin's use into ever broader categories of patients might have contributed to creating a public health crisis. That would have required a level of self-reflection and social responsibility that was incompatible with their business model.

What we're witnessing in 1920s Paris is a case study. and how corporate interests medical authority, cultural attitudes, and individual vulnerability can combine to create disaster. The pharmaceutical companies created and marketed a dangerous product. The medical establishment endorsed it and prescribed it widely. The cultural zeitgeist emphasized pharmaceutical solutions to life's problems and valorized altered states of consciousness. Individual people, trying to manage legitimate suffering or enhance their creative potential, made choices that seemed reasonable given the information available to them, and all of these factors together created a situation

where addiction proliferated through every level of society, from respectable bourgeois households to artistic studios, from wealthy neighbourhoods to working-class districts. This wasn't any one group's fault exactly, but it was absolutely a collective failure that destroyed countless lives and potential. Let's descend now into the basement jazz clubs of Paris, because this is where heroin's influence on culture becomes audible. The 1920s were jazz's golden age in Paris,

when American musicians fled racism and prohibition to find audiences that actually appreciated their art. The city's clubs became laboratories for musical innovation, places where traditional European sensibilities collided with African-American musical genius to create something entirely new. They also became spaces where heroin use was so normalized that it shaped the music itself,

creating what we might call a soundtrack of dependency that nobody fully recognised as such at the time. Jazz clubs in 1920's Paris were typically located in cellars and basements, partly for acoustic reasons, but mostly because that's where the rent was affordable, and the authorities were less likely to notice what you were doing. You'd descend a narrow staircase into a low-ceilinged room, thick with cigarette smoke and filled with small tables crammed uncomfortably close together. The stage, if you could call it that,

was usually just a slightly raised platform in one corner. The lighting was dim, partly for atmosphere and partly because electricity was expensive and club owners were chronically broke. The whole setup was designed to feel intimate and slightly illicit, which was perfect for both jazz and drug use, as both benefited from that aura of forbidden pleasure. The musicians performing in these clubs

were often struggling financially despite their talent. Jazz wasn't yet recognised as the significant art form it would later become, It was still considered somewhat disreputable, associated with vice and lower class entertainment. Musicians worked long hours for minimal pay, often performing the same set multiple times per night for different audiences. The schedule was exhausting. The pressure to perform consistently well despite fatigue was intense, and conveniently there was this readily available medicine that provided energy, confidence and relief from the physical discomfort of standing on stage for hours. Can you see where this is going?

Heroin use among jazz musicians in Paris started, like most heroin use, as a practical solution to a legitimate problem, a trumpet player dealing with chronic pain from an old injury, a singer-managing stage fright that was paralyzing her performances, a bassist trying to quiet the anxiety that came with performing for audiences who might or might not appreciate what he was trying to do musically. The initial use was therapeutic and intent, even if the therapy was self-prescribed. But because heroin was heroin, therapeutic. music use rapidly became addiction, and addiction became part of the jazz scenes cultural fabric. What's fascinating and disturbing is how heroin influenced the music itself.

Jazz in the 1920s was already characterized by improvisation, by musicians responding to each other in real time, creating spontaneous compositions that would never be exactly replicated. This required intense focus, musical skill, and the ability to listen carefully to what your fellow musicians were doing while simultaneously thinking ahead. to what you might play next. It's cognitively demanding. Heroin, particularly in moderate doses before tolerance gets too high, can create a sense of relaxed confidence that some musicians found enhanced their improvisational ability. The usual performance anxiety that might cause you to second-guess your choices or play it safe would dissolve, replaced by a feeling that whatever you played

would be exactly right. There's some truth to this initially. A moderately heroin-influenced musician might take more risks, try more adventurous, improvisational choices, play with less inhibition. Some genuinely brilliant performances emerge from musicians in this state. But, and this is crucial, these were musicians who were already extraordinarily talented. The heroine didn't create the talent. At best, it temporarily removed some psychological barriers that were inhibiting its full expression. And at worst, as tolerance developed and doses escalated, it destroyed the ability to perform at all. The rhythm of jazz began to change in subtle ways that reflected heroin's influence on perception. Time feels different when you're on opioids.

Moments can seem to stretch and elongate. A musical phrase that might feel too long when sober feels perfectly paced when influenced by heroin. Musicians who are using started naturally gravitating towards slower tempos, more sustained notes, longer improvisational passages that wandered and explored rather than driving toward resolution. Some of this was genuine artistic development. Jazz was evolving, becoming more sophisticated and complex. But some of it was also drug-influenced time dilation being translated into musical form. The audience's perception changed too. As heroin use spread through the clubs, not just among musicians but among regular patrons, the collective listening experience shifted.

An audience that's partially sedated has different preferences than a sober audience. They're more patient with extended improvisational passages. They're more willing to sit through experimental tangents that might not resolve in traditionally satisfying ways. They're less interested in energetic up-tempo pieces and more drawn to moody, introspective explorations. The musicians, consciously or unconsciously, adapted to these preferences. The music got slower, dreamier, more internal.

It became the soundtrack for communal sedation, though everyone involved would have described it as deep artistic appreciation. of complex musical innovation. Let's talk about the rituals that developed in these clubs, because this is where the line between musical venue and drug den becomes uncomfortably blurry. In the backrooms and bathrooms of jazz clubs, informal injection sites emerged. This wasn't initially the primary route of administration. Most people started with oral preparations, the syrups and tablets from pharmacies.

But injection delivers heroin to the brain faster and more efficiently, producing a more intense effect. As tolerance built and people needed stronger experiences, injection became more common. The clubs, with their dim lighting, cramped quarters, and general atmosphere of transgression, became convenient locations for this activity. The rituals around injection took on an almost ceremonial quality in some social circles. This was partly practical. You need someone to help you find a vein, particularly if you're injecting in poor lighting while already somewhat impaired,

but it also became a bonding experience. sharing drugs, preparing injections for friends, sitting together during the rush of heroin hitting your bloodstream. These became intimate social acts, moments of connection and shared experience. Some people romanticise this as beautiful, as evidence of deep friendship and trust. It was actually just a group of people enabling each other's addictions, but humans are remarkably good at reframing destructive behaviour in noble terms. The phrase, musical therapy, started appearing in discreet. about jazz clubs, though it meant something rather different than actual music therapy as we

understand it today. The idea was that attending jazz performances had therapeutic value, that the music could heal emotional wounds and soothe psychological distress. There was some truth to this. Music absolutely has emotional and even physiological effects that can be beneficial, but in the context of clubs where both musicians and audience members were heavily using heroin, musical therapy was largely code for getting high while listening to music. The therapeutic value was mostly the drugs, with the music providing pleasant accompaniment and social justification. Club owners were generally aware of the drug use happening on their premises and mostly looked the other way. Some actively facilitated it, recognising that heroin using musicians and

patrons were reliable customers who would show up regularly and stay for hours. A patron who's sedated and content will sit at a table buying occasional drinks all night without causing trouble or demanding much attention. From a business perspective, this was ideal. The fact that you were running what was essentially a drug den disguised as a music venue apparently didn't trouble most club owners, or if it did, the financial incentives overrode their concerns. Musicians developed reputations based partly on their talent and partly on their drug connections. If you were known as someone who could reliably source good heroin, you'd find yourself with many new friends who wanted to collaborate musically, which was convenient when you needed to split costs or wanted company while

using. The social networks within the jazz scene became entangled with drug distribution networks, creating a complex web where artistic collaboration, friendship and drug dealing were thoroughly mixed and difficult to separate. The physical toll on musicians was severe, though it manifested gradually enough that it was easy to miss or misattribute. A trumpet player's ambusha, the muscle control and mouth positioning required to play, would deteriorate. as heroin use progressed. Opioids affect fine motor control, and playing an instrument at a professional level requires extraordinarily precise motor control. A pianist's fingers would become less nimble, a singer's vocal control would suffer. These changes happened slowly, over months and years,

and could be explained away as fatigue, aging, or changing artistic priorities. But fundamentally, heroin was destroying the physical capabilities these musicians needed to perform their art. creative output also suffered in less obvious ways. Jazz is an improvisational art form, and improvisation requires your brain to function at a very high level. You're simultaneously accessing your musical knowledge, listening to what others are playing, generating new ideas,

executing them physically and monitoring the result. This is cognitively demanding. Heroin impairs cognitive function, particularly as tolerance develops and doses escalate. Musicians in advanced addiction might physically be on stage, going through the motions of performance, but the spark of genuine improvisation and creativity would be gone. They'd fall back on familiar patterns, playing the same licks and phrases they'd played hundreds of times before, no longer capable of the spontaneous innovation

that made their earlier work compelling. Some of the most tragic stories from this era involved musicians who showed extraordinary early promise, produced groundbreaking work in their 20s, and then spent their 30s in a haze of addiction, producing work that was increasingly derivative and uninspired, before eventually fading into obscurity or dying young. These weren't failures of talent or ambition. These were casualties of a drug epidemic that nobody was calling an epidemic yet because the victims were mostly poor, often black, and working in a musical form that respectable society didn't take seriously. Their losses weren't counted as significant cultural tragedies at the time, though in retrospect.

In retrospect, we can recognise that heroin destroyed an enormous amount of potential musical genius during this period. Now let's climb back up those basement stairs and enter an entirely different world, the private salons of Paris's wealthy elite. Because heroin wasn't just a problem in artistic communities and jazz clubs, it was also quietly consuming the upper class, though the form it took there was very different, wrapped in layers of social ritual and euphemism that made it almost invisible even as it was happening in plain sight. the women's salons of wealthy Parisian households in the 1920s were supposedly spaces for cultural

refinement and social connection. Ladies of Means would gather in elaborately decorated drawing rooms to discuss literature, admire art, exchange gossip, and maintain the social networks that were crucial to upper-class life. These gatherings had strict protocols appropriate dress, specific times, particular topics of conversation deemed suitable for refined company. Everything, was choreographed to demonstrate sophistication, education and social status. Into this highly structured environment, heroin arrived wearing the disguise of medicine, and it fit in perfectly. The introduction of heroin into elite social circles happened through the same route as everywhere else, pharmaceutical marketing and medical prescription. But the presentation was elevated to

match the social context. While working class users might be drinking heroin syrup from the bottle in a dimly lit apartment. Wealthy women were, taking their medicine, from crystal decanters at elegant tea services. The substance was the same. The social performance was entirely different.

Let's paint a scene. It's a Thursday afternoon in an opulent apartment in the eighth arrondissement. Madame Dubois, we're inventing names again, because naming specific historical individuals feels unnecessarily unkind is hosting her regular Thursday salon.

The room is appointed with everything required to signal wealth and taste. Persian rugs, impressionist paintings on the walls, furniture that's beautiful but deeply uncomfortable, fresh flowers arranged with more artistry than most of us apply to our entire lives. Six or seven women are arranged on various chairs and sofas, dressed in the height of 1920s fashion, which means they're all somewhat uncomfortable because fashion and comfort have never been close friends.

The conversation is about art, specifically whether the cubists have gone too far in fragmenting form and whether this represents genuine innovation or merely attention-seeking. It's the kind of discussion that sounds intellectual but doesn't really go anywhere, because nobody present has committed to a strong position. At some point, Madame Dubois mentions that she's feeling rather fatigued, the strain of maintaining such an active social calendar. Another woman sympathises, mentioning that she's been struggling with her nerves lately, the pace of modern life being quite exhausting. A third woman remarks that her doctor has recommended a wonderful new preparation for exactly such complaints.

This is the opening move in a social ritual that will culminate in several women using heroin together while maintaining the fiction that they're simply being responsible about their health. Madame Dubois rings for her maid, who returns with a silver tray bearing a small ornate box. Inside the box nestled in velvet are several glass syringes with silver plungers. Next to them are small vials of amber liquid, medical-looking but presented like perfume samples. This is heroin solution, prepared for injection, but the presentation screams luxury and legitimacy rather than drugs. The women approach this with the same ritualised delicacy they'd apply to serving tea. Would anyone care to take their medicine? Adam Dubois asks as if offering pastries.

Several women accept. The maid assists with the injections because hiring staff to handle your drug administration apparently seemed more refined than doing it yourself. Finding veins and depressing plungers with practice deficiency that suggests that this is a regular part of her duties. The women receiving injections maintain conversation throughout, discussing their doctor's recommendations and comparing various pharmaceutical preparations, treating the whole experience as a matter of medical necessity rather than recreational drug use. The euphemisms were elaborate and consistent. Nobody was getting high or using drugs. They were taking their medicine or attending to their health.

Addiction wasn't addiction, it was continued therapeutic need. Withdrawal wasn't withdrawal, it was recurrence of symptoms requiring ongoing treatment. The language created a protective barrier between reality and how they chose to perceive reality. This is the privilege wealth affords, the ability to frame destructive behavior in whatever terms allow you to continue it without cognitive dissonance. The equipment itself was remarkable. While working-class users might be sharing needles and club bathrooms, wealthy women had personal syringes made of glass and silver, sometimes with their initials engraved, stored in fitted cases lined with silk. These weren't medical supplies, they were luxury accessories, status symbols that happened to be used for drug administration. Some were genuinely beautiful objects.

You can find examples in museums now, though the museum labels usually emphasised the craftsmanship while downplaying the whole device for injecting narcotics aspect. The social protocols around heroin use in elite circles were strictly maintained. You didn't discuss the actual effects of the drug, any more than you'd discuss the intimate details of bodily functions. You didn't acknowledge that this was addiction, even as you were clearly demonstrating all the signs of addiction. You certainly didn't mention the cedier aspects, the need to visit multiple doctors to maintain supply, the occasional necessity of acquiring drugs through less reputable channels, when your regular physician became concerned, the morning sickness of withdrawal that you explained a way as merely feeling

under the weather. These salons maintained a veneer of cultural sophistication, even as they were fundamentally drug parties. After the medicine was administered, the character of the conversations would shift, becoming more languid and less focused. The intellectual discussions would peter out, replaced by comfortable silence or desultory remarks. Someone might sit at the piano and play something slow and dreamy. The afternoon would stretch on, hours passing in a pleasant haze, until a Eventually the guests would drift away, promising to return next week for another refined gathering that was actually a group heroin session. The tragic irony is that many of these women were patrons of the arts.

They funded artists, purchased paintings, attended concerts, supported literary magazines. Their wealth was supposed to facilitate cultural production and innovation. But as their heroin use intensified, their engagement with art became increasingly passive and eventually nearly non-existent. They still hosted salons and attended events, maintaining the social performance of being cultured, but the actual patronage declined. Artists who'd relied on their support

found commissions drying up. Purchases became less frequent. The women who'd been important nodes in the network of cultural support were still present physically, but absent in any meaningful sense. This same pattern replicated through the wealthy households of Paris. Husbands, busy with business,

busy with business, and largely absent from the afternoon social scene, often had no idea their wives were addicted to heroin. The women were skilled at maintaining appearances, they dressed appropriately, managed household staff, fulfilled their social obligations. The addiction was completely invisible from the outside, hidden behind layers of money, social convention and euphemism. Only in private moments did the reality become apparent, the desperate morning need for the first dose, the careful, rationing of supply, the anxiety about running out, the growing tolerance requiring larger and larger amounts. The medical establishment was complicit in maintaining this facade. Doctors who served

wealthy clients were well compensated for their discretion. If a patient was clearly addicted to heroin, you didn't confront them about it. That would be gauche and might cost you a wealthy client. Instead, you continued prescribing, perhaps with gentle suggestions about moderation that everyone knew wouldn't be followed. You maintained the fiction that this was legitimate medical treatment, even as you watched your patient's health deteriorate from drug use. Professional ethics apparently meant something different when large fees were involved. Some doctors developed significant portions of their practice around servicing wealthy addicts. They'd maintain networks of patients who all had chronic conditions requiring ongoing opioid therapy. They'd write prescriptions

liberally, charging substantial consultation fees for appointments that were essentially just prescription renewal. A few doctors became quite wealthy through this arrangement, which must have created interesting moral calculations. On one hand, you're enabling addiction and watching patients harm themselves. On the other hand, you're making excellent money and the patients are certainly willing participants. Medical ethics in the 1920s were apparently flexible enough to accommodate this tension. The children in these wealthy households, were often vaguely aware something was wrong but didn't have the framework to understand what they were seeing. They'd noticed their mother seemed very sleepy in the afternoons. They'd observe

strange rituals around medicine-taking that seemed more elaborate than necessary. They might overhear hushed conversations between parents about doctors or supply issues. But nobody explained what was happening, because that would require acknowledging it openly, which would violate the careful pretense everyone was maintaining. So children grew up in households where addiction was present, but unspoken, learning early that some truths are too uncomfortable to voice aloud. The social networks among wealthy women facilitated the spread of heroin use within their class. If one woman in your social circle was using heroin for her nerves, and she seemed to be managing life successfully, still hosting her salons, still dressing well, still maintaining

her household, then heroin seemed like a reasonable solution to your own anxiety or insomnia. The fact that your friend was actually addicted and carefully hiding the extent of her problem, wasn't visible to you. You just saw the successful performance, not the deterioration happening beneath it. So you'd ask her doctor for a similar prescription, or she'd recommend her physician to you, and suddenly another wealthy household would have another hero-independent woman, and the cycle would expand through recommendation and social modelling. The pharmaceutical companies absolutely catered to this market. Advertisements in upscale magazines featured elegant women taking refined medicine for nervous complaints. The imagery was all about

sophistication and modernity. This was how forward-thinking people managed the stresses of contemporary life. The ads never showed addiction, withdrawal, or the grim reality of long-term opioid use. They showed beautiful, successful, happy people using pharmaceutical products to maintain their successful happy lives. It was aspirational marketing that happened to be advertising a substance that would ruin your life if used as suggested. The disconnect between public image and private reality in these wealthy households was often vast. Publicly, these were families representing the pinnacle of Parisian society-educated, cultured successful. Privately, multiple family members might be struggling with addiction. The household budget might be strained by drug costs despite

substantial income. Relationships might be deteriorating under the stress of active addiction, and everyone was maintaining an exhausting performance of normalcy. The energy required to keep up this pretense was enormous and it couldn't be sustained indefinitely. Eventually something would crack a health crisis, a financial emergency, someone outside the family noticing something was wrong. But before the crash came, these households existed in a strange liminal space, where addiction was simultaneously central to daily life and completely unacknowledged. The heroin use shaped everything, schedules, social activities, household management relationships, but it was never named, never addressed directly. It was the elephant in the drawing room that everyone carefully navigated around

while discussing art and literature and the weather. Comparing the jazz club scene to the elite salon scene reveals how class-shaped the experience of addiction in 1920s Paris. The substance was the same, the brain chemistry was the same, the progression from Eustre dependence was the same, but the social context was entirely different. Jazz musicians using heroin in club bathrooms were engaging in obviously illicit behaviour, even when the drug was technically legal. Wealthy women injecting heroin in their drawing rooms with silver syringes were engaging in refined medical self-care. One group was stigmatised, the other was invisible. One group faced social consequences, the other was protected by wealth and social status. The drug didn't discriminate,

but society certainly did in how it responded to drug use across different populations. Both contexts involved significant self-disciplines. Both contexts involved significant self-discipline. deception. Jazz musicians convinced themselves that heroin enhanced their creativity and was therefore a professional tool. Wealthy women convinced themselves they were addressing legitimate medical needs with appropriate pharmaceutical interventions. Both groups developed elaborate rationalizations for continued use even as negative consequences accumulated. Both groups created social environments that normalized and facilitated drug use. And both groups were ultimately trapped in addiction that would destroy significant aspects of their lives, regardless of how they chose to frame or rationalize

it. The cultural impact of heroin on both these worlds, jazz culture and elite culture, was profound and lasting. Jazz music was shaped by the drug in ways that persisted long after individual musicians quit using or died. The aesthetic preferences developed during this period, the emphasis on mood and introspection, the extended improvisational passages, the slower tempos, became part of jazz's vocabulary even when performed by sober musicians. The cultural association between jazz and drugs was established during this period and would haunt the music for decades, making it easier to dismiss jazz as disreputable and making it harder for musicians to be taken seriously as artists. Similarly, the elite world's encounter with heroin had lasting effects. The patterns of pharmaceutical use

established in 1920s salons, the use of prescription medications to manage the stresses of affluent life, the normalisation of regular drug use as refined self-care, the deployment of euphemism and social ritual to obscure addiction, all of this would persist and evolve in wealthy circles throughout the 20th century. The substances changed, barbiturates, benzodiazepines, prescription amphetamins, but the basic dynamic remained remarkably consistent. Wealthy people with access to compliant doctors would use pharmaceutical solutions to manage their psychological distress, would develop dependencies they refuse to acknowledge, and would maintain elaborate pretences of normalcy while struggling privately with addiction. The medical establishment's failure to address

addiction in wealthy patients also had lasting consequences. It established precedent for doctors to be complicit in addiction among affluent clients to prioritize maintaining wealthy patients over ethical prescribing practices. This dynamic would repeat throughout pharmaceutical history, most notably in the recent opioid epidemic where doctors prescribed extraordinary quantities of oxycontin and similar drugs to patients who were clearly addicted, maintaining the fiction of legitimate pain management while collecting fees and avoiding uncomfortable confrontations. The playbook was written in 1920s Paris, and it's been used repeatedly ever since. We need to examine how the medical establishment turned individual prescribing errors into systematic educational doctrine,

because this is where institutional failure becomes genuinely impressive in its scope and stubbornness. Medical schools in 1920s France weren't just failing to recognise the heroin problem. They were actively teaching the next generation of doctors that heroin was an appropriate first-line treatment for a breathtaking range of conditions. This wasn't some rogue professor with unconventional ideas. This was mainstream medical education, backed by professional associations, encoded in textbooks, and reinforced through every level of medical training. They were running a curriculum in creating addiction, though they would have been horrified by that description.

Let's start with the medical school lecture halls, because this is ground zero for how bad ideas become entrenched knowledge. A young medical student in Paris in 1923, earnest and idealistic about healing the sick, sits in a pharmacology lecture. The professor distinguished, published, respected, is discussing therapeutic approaches to respiratory conditions. He explains that heroin is a remarkably effective cough suppressant,

superior to codeine in potency and speed of action. He mentions the chemical structure, the mechanism of action on opioid receptors, the appropriate dosing regimens. He might briefly note that heroin can be habit-forming if misused, but he emphasises that this is rare with proper medical supervision and appropriate patient selection. The student takes careful note,

committing this to memory because it will definitely be on the exam. What the professor doesn't mention, possibly because he doesn't fully understand it himself, is that proper medical supervision is nearly meaningless with opioids because tolerance develops regardless of how carefully you monitor patients. He doesn't explain that appropriate patient selection is impossible because anyone can become addicted to heroin with sufficient exposure. He doesn't acknowledge that the rare cases of addiction are actually becoming increasingly common, representing not outliers, but the predictable consequence of widespread prescribing.

These omissions aren't necessarily malicious. They reflect the professor's own incomplete understanding, his reliance on pharmaceutical company literature, and his institutional position within a medical establishment that has already committed to heroin as a valuable therapeutic tool and is reluctant to reverse course. The textbooks told the same story. Medical reference books from this era include sections on heroin that read like pharmaceutical marketing brochures rather than objective medical literature. They list extensive indications, cough, dyspnea, anxiety, insomnia, pain, even diarrhea positioning heroin as a versatile tool in the therapeutic arsenal. They provide detailed dosing information, often suggesting starting doses that were quite high and recommending rapid escalation if initial doses proved insufficient. The sections on

adverse effects and contraindications were brief, almost dismissive. May cause constipation and drowsiness, used with caution in respiratory depression. Nothing about the catastrophic addiction potential, nothing about withdrawal, nothing about the probability that long-term use would destroy patients' lives. Some textbooks included case studies meant to illustrate appropriate clinical use of heroin. These were almost universally disaster stories that the authors had somehow misinterpreted as success stories. A typical example might describe a patient with chronic cough who was started on heroin therapy and showed excellent symptomatic relief. The case would note that the patient required dose increases over time to maintain effectiveness,

which the authors interpreted as evidence of progressive disease rather than tolerance. It would mention that attempts to discontinue therapy resulted in return of symptoms, which was actually withdrawal being mistaken for disease recurrence. The case would conclude that the patient required ongoing heroin therapy indefinitely, which the authors presented as a successful outcome. Modern readers, looking at the same case, would see obvious addiction being managed as chronic disease, but the authors, trapped in their conceptual framework, couldn't see what now seems glaringly obvious. The professional medical associations played a crucial role in legitimising and promoting heroin use.

These organisations published guidelines and position statements that carried enormous authority. When the French Medical Association issued recommendations for treating respiratory conditions that included heroin as a first-line therapy, individual doctors took that as definitive guidance. When specialty societies published consensus statements on managing anxiety that endorsed opioid use, physicians felt they were on solid ground prescribing these medications. The associations weren't conspiring to harm patients. They genuinely believed they were synthesizing the best available evidence and providing valuable guidance. They were actually amplifying pharmaceutical company messaging

and enshrining treatment approaches that were creating an epidemic of addiction. The concept of supportive dose escalation is particularly worth examining because it perfectly encapsulates how medical thinking went catastrophically wrong. The idea was that as patient's conditions evolved, their medication needs would naturally increase. If a patient required higher doses of heroin to manage their cough or anxiety, this meant their underlying condition was worsening, not that they were developing tolerance. The appropriate medical response was to support the patient by increasing their dose to whatever level, provided symptomatic relief. This sounds compassionate and patient-centered until you realize it's a recipe for helping patients escalate their way into severe addiction while assuring them they're receiving appropriate medical care. Medical training included almost nothing about

recognising or treating addiction. This wasn't an oversight exactly addiction medicine as a specialty didn't really exist yet, but it meant that doctors graduated with extensive knowledge about prescribing opioids and essentially no knowledge about what to do when patients became addicted, they could recognise the most extreme cases. Someone who'd completely deteriorated, lost everything, was obviously drug-seeking, but the vast majority of addiction cases, people who are maintaining some level of function while being thoroughly dependent on heroin were invisible to them. They looked like patients with chronic conditions requiring ongoing medication, which is exactly how the doctors had been trained to conceptualise them.

Now there were dissenters. This is important to acknowledge because the medical establishment wasn't monolithic. Some physicians recognised early that heroin prescribing was creating serious problems. By the early 1920s, scattered voices were raising concerns. A doctor working in a charity hospital would notice that many of his patients

seeking treatment for various ailments were actually suffering from heroin addiction. A psychiatrist would observe that patients admitted for anxiety had often started with heroin prescriptions that led to dependence. A general practitioner would recognize the pattern of patients returning constantly for refills, needing ever-higher doses, showing signs of deterioration that didn't match their reported conditions. These dissenters tried to raise alarms.

They published papers in medical journals describing cases of heroin addiction and arguing for more cautious prescribing. They gave presentations at medical conferences warning about the drug's dangers. They wrote letters to medical journals. associations requesting that guidelines be revised, and they were largely ignored or actively suppressed, which tells us something depressing about institutional medicine's ability to acknowledge and correct its own errors. The suppression wasn't necessarily centrally coordinated. Nobody was running around silencing heroin critics in some sinister conspiracy. It was more subtle and more insidious.

Papers raising concerns about heroin would have difficulty getting published in prestigious journals which were funded by pharmaceutical advertising and reluctant to publish content that might upset advertisers. Conference presentations that questioned heroin safety would be relegated to less prominent time slots or rejected entirely in favour of presentations that aligned with the prevailing consensus. Doctors who publicly criticised heroin prescribing might find themselves professionally marginalised, excluded from influential committees, passed over for academic positions. The most effective suppression was intellectual rather than administrative. Decenters would raise concerns about heroin, and the medical establishment would respond with

what seemed like reasonable objections. Yes, some patients become dependent, but that's because they have underlying conditions that require ongoing treatment. The cases you're describing represent inappropriate prescribing, not problems with the medication itself when used correctly. You're confusing physical dependence, which is normal with any regular medication, with addiction, which is a moral and psychological failing. These responses sounded sophisticated and medically informed. They were actually elaborate rationalizations for continuing a profitable and professionally convenient practice

in the face of mounting evidence of harm. Some dissenters were dismissed as moralists trying to impose their values on medical practice. If you argued that heroin was too dangerous to prescribe widely, you might be accused of being approved, of wanting to deny patients' effective relief from suffering because of outdated moral concerns. This was effective rhetorical maneuvering

because nobody wanted to be seen as moralistic or anti-scientific. Medicine was supposed to be objective, evidence-based, freed from the moral judgments that had characterized earlier eras. So concerns about heroin got reframed as moral panic rather than legitimate medical caution, and doctors who might have been sympathetic to the concerns decided they didn't want to be associated with what was being portrayed as backward thinking.

A few particularly persistent dissenters managed to gain some traction. There were doctors who published extensive case series documenting the progression from therapeutic use to severe addiction. There were researchers who conducted systematic studies showing the prevalence of heroin dependence among patients prescribed the drug for medical reasons. There were clinicians who developed early treatment protocols for helping patients withdraw from heroin and argued these should be more widely available. These efforts did eventually contribute to changing medical opinion and politics,

policy, but the process was agonisingly slow. We're talking years, sometimes decades, between when evidence of harm became apparent and when medical practice actually changed in response. The institutional resistance to acknowledging the heroin problem wasn't just about money or pride, though both played a role. It was also about the sheer difficulty of admitting systematic error. Medical schools had taught thousands of doctors that heroin was appropriate therapy. Professional associations had issued guidelines in doctors. endorsing its use. prestigious journals had published favourable research. Prominent physicians had built careers partly on their expertise in opioid therapy. To acknowledge that all of this was wrong

required an institutional humility that most organisations struggle to achieve. It's much easier to double down on existing positions, to explain away contradictory evidence, to gradually and quietly shift practice over time while never explicitly admitting error. The parallels to more recent medical mistakes are striking and uncomfortable. The medical establishment's handling of the opioid crisis in the late 20th and early 21st centuries followed a remarkably similar pattern. Aggressive pharmaceutical marketing, medical guidelines endorsing liberal opioid prescribing, dismissal of early warnings, eventual recognition of the problem only after enormous harm had been done. The fact that medicine made essentially the same mistake twice, separated by about 80 years, suggests something troubling

about medical institutions' ability to learn from history. Or perhaps it suggests that the structural factors promoting medical error financial incentives, professional momentum, institutional pride, are powerful enough to override historical knowledge. Now let's shift our attention from medical institutions to the broader economic ecosystem that heroin created in Paris, because addiction doesn't just affect users and their families, it creates economic ripples that spread through countless industries and businesses that benefit from drug use without necessarily recognising or acknowledging their role in the system. Start with glass blowers and bottle manufacturers.

Every heroin preparation needed a container and Paris in the 1920s was going through bottles at an extraordinary rate. Glass manufacturers were producing hundreds of thousands of bottles annually for pharmaceutical use. This was good business. The manufacturers didn't particularly care what went into the bottles that wasn't their concern. They made bottles to pharmaceutical specifications, delivered them to pharmaceutical companies and collected payment. The fact that these bottles would eventually contain highly addictive drugs that would ruin countless lives was someone else's problem. This is what we might call willful ignorance as a business model. You don't ask questions about how your products will be used because knowing might create moral complications that could

interfere with profits. Some glass manufacturers specialised in pharmaceutical bottles, developing particular expertise in producing the amber and cobalt blue glass that was preferred for light-sensitive medications. They competed for pharmaceutical company contracts based on quality, price and aesthetic appeal. The most successful manufacturers produced bottles that were not just functional, but beautiful remember. We talked earlier about how important presentation was to heroin's marketing. These manufacturers were essentially producing the packaging that made heroin consumption seem respectable and medical. They were complicit in the addiction epidemic, though they would never have seen themselves that way. They were just making bottles, quality bottles, attractive bottles.

What happened to be put in those bottles was none of their concern. The syringe manufacturers were similarly removed from the direct harm they were facilitating. The 1920 saw significant advances in syringe technology, producing increasingly refined and reliable injection equipment. Some manufacturers catered specifically to the luxury market. market, producing those silver-plated syringes we mentioned earlier, sold in fitted cases to wealthy clients. These weren't medical supply companies exactly. They were more like jewelers who happened to specialize in drug paraphernalia. They advertised in upscale magazines, emphasizing the craftsmanship and elegance of their products. The fact that these beautiful

objects were being used to inject heroin was mentioned bleakly if at all. The marketing focused on medical self-care, modern convenience, personal high-demean, and personal hygiene. gene. The reality was that they were selling very expensive equipment for getting high. The real estate market in Paris was significantly impacted by heroin use in ways that mostly benefited landlords and property owners. Remember those private rooms we mentioned in jazz clubs where people would inject. Someone owned those properties. Someone was collecting rent from establishments that were partly functioning as drug dens. Some landlords were probably oblivious to what was happening on their properties. Others certainly knew, and deliberately looked the other way because drug-using

tenants were reliable tenants. They needed a place to use. They'd pay rent to maintain that access, and they were often too compromised to complain about poor conditions or demand maintenance. Some properties became known as safe houses, where heroin users could gather, purchase drugs and use without fear of immediate legal consequences. These weren't shooting galleries in the modern sense. Many were actually quite respectable-looking apartments or rooms above shops. but they functioned as nodes in the distribution and consumption network. The property owners charged premium rents for these spaces because the tenants weren't just paying for the physical room.

They were paying for the owner's discretion and the relative safety from police interference that the location provided. This was a profitable arrangement for landlords willing to rent to questionable tenants, and many were willing because money has a remarkable ability to overcome moral qualms. The Postal Service became an unwitting accomplice in heroin distribution, though this role was completely invisible to postal workers themselves. Remember we discussed how tourists and expatriates would mail heroin back to their home countries and how users in other cities would request that friends in Paris mail them supplies?

All of this went through the postal system. Postal workers were handling packages containing illegal or quasi-legal drugs, though the packages looked completely legitimate, just small parcels marked as containing medicine or personal effects. The postal service's reliable operation enabled international heroin distribution, though nobody at the post office thought of their work in those terms. They were just delivering mail. The fact that some of that mail contained substances that would eventually be classified as some of the most dangerous drugs in existence was outside their awareness

and outside their responsibility as they understood it. International postal networks became particularly important as different countries implemented varying restrictions on heroin. France remained relatively permissive longer than some other nations, which meant Paris functioned as a source for users in countries with stricter controls. Postal workers in Paris would process outgoing packages destined for London, New York, Berlin, most of them completely innocent, but some containing carefully concealed heroin supplies. Customs officials at destination countries were supposed to intercept these shipments, but enforcement was inconsistent. Many packages made it through. The postal services efficiency and reliability, normally civic virtues, became enablers of international

drug trafficking. Banking and finance were also entangled in the heroin economy, in ways that were invisible to most bankers. Pharmaceutical companies deposited enormous profits from heroin sales in French banks. Doctors deposited fees earned from prescribing heroin and managing addicted patients. Pharmacies deposited revenue from heroin sales. Legitimate businesses involved in the heroin supply chain manufacturers, distributors, retailers, all conducted their financial transactions through normal banking channels. The banks weren't doing anything wrong exactly. They were providing standard financial services to apparently legitimate businesses. But the net effect was that French financial institutions were processing and profiting from

money that was fundamentally derived from addiction. Some banks probably noticed unusual patterns, a doctor who was depositing far more cash than would be expected from their apparent patient load, a pharmacy with revenue that seemed disproportionate to its size. A pharmaceutical company experiencing explosive growth. Did they investigate? Did they care? Banking then, as now, operated on a principle of know your customer, but that knowledge extended only as far as ensuring the money being deposited was coming from legal sources. Heroin was legal, or at least in a regulatory grey area, so there was no particular reason for banks to scrutinise these transactions. They processed the deposits, invested the money, paid interest, collected fees, and enriched themselves from an

economy that was built significantly on addiction. Insurance companies found themselves in an awkward position, as the heroin problem became more apparent. Life insurance policies didn't typically include exclusions for drug use, because that wasn't yet recognised as a significant risk factor. So insurers found themselves paying death benefits for people who died from heroin overdoses or complications of long-term heroin use. Health insurance still a relatively new concept in the 1920s would cover medical treatment related to heroin use without necessarily recognising it as such. A patient might be treated for respiratory infections, malnutrition, abscesses from injection, and the insurance company would pay these claims without connecting

them to underlying drug use. Some actuaries and insurance company executives began noticing trends, mortality rates among certain populations, jazz musicians, artistic communities, even some wealthy demographics were higher than expected, claims for certain types of medical treatment were increasing. The actuarial data was showing patterns that suggested something was wrong, but interpreting these patterns correctly required connecting dots that most insurance professionals weren't prepared to connect. They might adjust premiums for certain occupational groups or demographic categories without understanding that what they were really responding to was heroin use prevalence. The insurance industry was absorbing financial

costs of the heroin epidemic, while mostly remaining oblivious to what was driving those costs. transportation networks, trains, taxis, even the early automobile infrastructure facilitated heroin distribution without any awareness of doing so. Heroin supplies moved from manufacturers to distributors to pharmacies via train freight. Users travelled to different neighbourhoods or even different cities to acquire supplies from multiple sources. Dealers, though we shouldn't use that term too loosely, as most were just users sharing supplies moved products through normal transportation channels. train conductors, taxi drivers, freight handlers were all moving heroin around Paris and around France without knowing it. The packages looked legitimate. The passengers looked respectable. The whole operation was disguised as normal commerce and normal life.

The hospitality industry hotels, boarding houses, furnished apartments benefited from heroin tourism without acknowledging or perhaps even noticing it. People came to Paris specifically because heroin was easily available. They'd stay for. for weeks or months, paying for accommodations, eating in restaurants, spending money in the local economy. Some were tourists combining cultural experiences with easy drug access. Others were serious addicts who'd come to Paris because they'd exhausted their options elsewhere. Hotel owners and managers mostly didn't ask too many questions about what guests did in their rooms, as long as they paid their bills and didn't cause obvious disturbances. The hospitality industry was profiting from drug tourism disguised as cultural tourism.

Medical supply companies sold equipment and supplies that ended up being used for heroin consumption, not just syringes, but also alcohol for sterilisation, cotton for filters, tourniquets ostensibly for medical purposes but frequently used to raise veins for injection. These companies maintained the fiction that their products were for legitimate medical use, which technically they were, but they certainly knew or should have known that significant portions of their sales were going to support addiction. Some medical supply stores near known heroin hotspots did extraordinary business in injection supplies. The owners weren't idiots.

They understood what was happening. But business was business, and as long as they were selling legitimate products to adult customers, they felt no particular obligation to refuse sales or report suspicious purchasing patterns. The advertising industry profited handsomely from pharmaceutical company spending. Magazines and newspapers that carried heroin advertisements collected substantial revenues. from pharmaceutical companies. Ad agencies created the marketing campaigns that promoted heroin as safe and effective. Graphic designers produced the beautiful labels and packaged designs. Copywriters crafted the persuasive text that convinced people, heroin was appropriate medicine for their ailments.

All of these professionals were paid from profits ultimately derived from addiction, though they would have resisted that characterization strenuously. They were providing creative services to legitimate pharmaceutical companies for legal products. The fact that their creative work was facilitating an addiction, epidemic would have seemed like an unfair accusation. They weren't responsible for how the products were used, only for effectively communicating their intended purposes. Print shops and bookbinders produced the medical textbooks, pharmaceutical guides, and professional journals that promoted heroin use within the medical community. They printed the prescription pads doctors used to prescribe heroin. They produced the labels that went on bottles. They manufactured the informational inserts that

came with medications. Every piece of printed matter associated with heroin moved through the printing industry, generating work and profit for printers who were just fulfilling contracts and had no particular stake in the content they were reproducing. The legal profession benefited in more subtle ways. As the heroin problem worsened, there was increased demand for lawyers to handle matters related to drug use. Property disputes when addicted individuals defaulted on obligations, family law issues when addiction destroyed marriages, criminal defence when users were arrested for related offences. Some lawyers developed specialisations in handling the legal complications that arose from addiction. They weren't drug lawyers exactly, that term would come later, but they were professionals

who understood how to navigate the legal issues that heroin use created. They charged substantial fees for this expertise, building practices on the legal wreckage of the addiction epidemic. Accounting firms handled the books for pharmaceutical companies, pharmacies, and medical practices that were profiting from heroin. They ensured proper tax reporting on drug sales. They audited pharmaceutical company finances. They provided consulting services on maximizing profitability of pharmaceutical operations. Accountants are professionally bound to maintain confidentiality, and to focus on financial accuracy rather than moral judgment about how clients make their money. So they performed their professional duties competently,

ensuring that the heroin economy was properly documented financially without concerning themselves with the human costs underlying those financial figures. The medical education industry, the companies that produced anatomical models, medical charts, educational materials for medical schools, included heroin prescribing in their materials because that's what the medical curriculum required. They produced posters showing proper dosing regimens.

They created reference cards for medical students listing heroin, among appropriate treatments for various conditions. They manufactured the teaching materials that trained new doctors in the prescribing practices that were creating addicts. They were just responding to market demand for educational materials, but the market was demanding materials that taught systematic medical error. Restaurants and cafes benefited from the heroin economy

in straightforward ways. Addicted people still needed to eat. Users gathering socially would meet in cafes. Dealers conducting transactions would do so over coffee or meals. Some establishments became known as places where you could connect with suppliers or meet other users. The owners might or might not have been aware of this reputation, but they benefited from the additional business regardless. A cafe that became a known meeting spot for users would see increased traffic, more revenue, better profits. The fact that they were indirectly facilitating drug dealing wasn't so.

something they needed to acknowledge or address as long as the obvious disruption remained minimal. The clothing and fashion industries had complicated relationships with heroin use. On one hand, long sleeves became fashionable partly because they concealed injection marks. Luser clothing styles that emerged in the 1920s made it easier to hide the physical deterioration that came with addiction. Some fashion trends were inadvertently enabling heroin users to maintain their public presentation, even as they were privately struggling with addiction. On the other hand, the fashion industry suffered when wealthy patrons addicted to heroin

diverted spending from clothes to drugs, or when addicted individuals in the industry models, designers, boutique owners, saw their productivity and creativity decline. The entertainment industry was thoroughly entangled with heroin in ways we've already discussed with jazz, but it extended beyond music. Theatre productions, film sets, literary readings, these cultural events were often attended or performed by people who were actively using heroin. The entertainment industry's financial health depended partly on the cultural vitality of Paris,

which was simultaneously being enhanced and undermined by widespread drug use. Some entertainers produced brilliant work despite or perhaps temporarily assisted by heroin use. Many more saw their talents destroyed by addiction. The net effect on entertainment quality is impossible to calculate, but the economic impact was real, wages paid, tickets sold, productions funded, all of it flowing through an economy where heroin

played an increasingly central role. The municipal government of Paris derived tax revenue from all of this economic activity without fully understanding its source. Pharmaceutical companies paid business taxes, pharmacies paid licensing fees. Property owners paid property taxes on buildings where heroin was being sold and consumed. All of this revenue flowed into city coffers and funded public services, the city of Paris was financially benefiting from an addiction epidemic affecting its own citizens. Some city officials were certainly aware that heroin use was becoming problematic, but the connection between that social problem and the tax revenue supporting city services was probably not explicitly made. Government tends to compartmentalise the Health Department

worries about public health, the finance department worries about revenue, and rarely do those concerns integrate into a coherent understanding of how problematic social phenomena can be economically beneficial to government budgets. The scope of this shadow economy is staggering when you map it out completely. You have manufacturing, distribution, retail, real estate, finance, insurance, transportation, hospitality, advertising, printing, legal services, accounting, education, food service, fashion, entertainment and government all touched by and benefiting from the heroin economy. Most participants in this economy were completely unaware of their role in a larger system of addiction and harm. They were just doing their jobs, running their businesses, providing

goods and services for which there was legitimate demand. The fact that all of this legitimate economic activity was ultimately built on a foundation of addiction was invisible to most people because the connections were too diffuse, too indirect, too well disguised by the patina of medical legitimacy that heroin retained. This is one of the insidious features of legalised or quasi-legalised drug markets. They create economic incentives that extend far beyond the direct producers and sellers. Once addiction is generating substantial economic activity, you have entire industries and businesses that benefit from continued addiction, even if they're not directly involved in selling drugs. These beneficiaries have no particular incentive to support efforts to address the addiction problem,

because doing so would harm their economic interests. They're not evil people consciously profiting from human suffering. Most of them are just ordinary business people responding to market opportunities, but their collective economic interest in maintaining the status quo creates powerful resistance to reform. This same dynamic plays out in modern contexts around various forms of legalized vice gambling, alcohol, recently marijuana in jurisdictions where it's been legalised. You get this extensive network of businesses that benefit economically from the core activity, and they become a constituency opposed to regulation or restriction, even when public health concerns suggest such measures

would be beneficial. The medical establishment, pharmaceutical industry, and all the auxiliary businesses benefiting from heroin in 1920s, Paris created an economic and political coalition that had strong incentives to maintain the system, even as evidence of harm accumulated. Changing course required overcoming not just intellectual inertia and professional pride, but also substantial economic interest that benefited from maintaining the destructive status quo. Now we need to zoom out from the streets of Paris and examine the international supply chain that kept those elegant pharmacy bottles filled with heroin, because this story isn't just about one city. It's about the emergence of the first truly modern narcole.

robotics trafficking network, complete with international manufacturing, sophisticated logistics, legal camouflage, and organisational structures that would define drug trafficking for the next century. The people building this system didn't think of themselves as criminals exactly. Many of them were operating in legal grey areas, exploiting regulatory gaps between nations. But they were absolutely creating the prototype for modern organised drug trafficking, establishing patterns and practices that cartels and trafficking organisations would refine and replicate for decades to come. Let's start at the source, which means starting with opium poppies. The raw material for morphine and therefore for heroin came primarily from Turkey and the Balkans in the 1920s.

These regions had been cultivating opium for centuries, initially for legitimate medical use. The cultivation itself was legal and often government sanctioned. Farmers grew poppies like any other. crop, harvested the opium latex and sold it to authorised buyers. This was agricultural commerce, completely above board. The opium would be refined into morphine through a chemical process that was also legal and conducted in licensed facilities. So far everyone's following the rules, operating within the law, engaging in legitimate international trade. Here's where it gets interesting. Morphine is scheduled two in most modern regulatory systems, recognized as having

medical value but tightly controlled due to abuse potential. But in the 1920s, international drug control was still in its infancy. The League of Nations had established some conventions attempting to regulate narcotics trade, but enforcement was weak and compliance was voluntary. Countries could theoretically sign onto international agreements limiting drug production and trade, but actually implementing and enforcing those commitments was another matter entirely. This created a patchwork of regulations where something might be illegal in one country but perfectly legal in the neighbouring country, which meant that international trafficking could be disguised as legal commerce simply by routing it through the right jurisdictions. Switzerland became crucial to this system,

though Swiss authorities would probably have preferred not to have this distinction. Switzerland had several pharmaceutical companies and chemical laboratories with the expertise to convert morphine into heroin. The process isn't particularly complex from a chemistry standpoint you're acetylating morphine, which requires acetic and hydride and some basic lab equipment, but doing it at industrial scale requires expertise and infrastructure. Swiss facilities had both. They also had something even more valuable. They were operating in a country with relatively permissive drug regulations that didn't ask too many questions about where morphine came from or where finished heroin was going. The typical route went something like

this. Opium grown in Turkey or Bulgaria would be legally exported to a morphine, refinery, often in France or Switzerland. The morphine would then be transported to a Swiss laboratory where it would be converted into heroin. This conversion was technically legal in Switzerland for medical purposes, though medical purposes was interpreted quite liberally. The heroin would then be exported theoretically to countries where it was legal for pharmaceutical use, though the documentation about final destinations was often creative or entirely fictional. Each step in this process had paperwork declaring it was legal commerce for legitimate medical purposes. The fact that the quantities being produced vastly exceeded any plausible medical

need was somehow not seen as concerning by the authorities responsible for oversight. Let's spend some time with one of these Swiss laboratories because the operations were remarkable in their mundane criminality. Picture industrial building in a small Swiss town, maybe near Basel, where several pharmaceutical companies operated. From the outside, side, it looks completely legitimate clean, well maintained, with professional signage identifying it as a pharmaceutical facility. Workers arrive for regular shifts. There's an office handling paperwork and shipping logistics. The whole operation has the appearance of normal corporate activity, which is excellent camouflage for what's actually happening inside. In the laboratory,

chemists are synthesizing heroin at a rate that would make buyer jealous. They're processing hundreds of kilograms of morphine per month, converting it into heroin that's being packaged and prepared for shipment. The chemists themselves are often well-educated professionals who could be working for legitimate pharmaceutical companies, and indeed some of them previously did before discovering that the grey market heroin business paid significantly better than normal pharmaceutical work. They're not stereotypical criminals, they're chemists doing chemistry, and if some of that chemistry happens to be producing substances that will be illegally trafficked to feed addiction in other countries, well, that's not really their concern.

They're following the formulas, maintaining quality control and collecting their paychecks. The moral implications of their work are somebody else's problem. The laboratory maintains meticulous documentation, showing that all their production is for legitimate medical export. They have purchase orders from pharmaceutical wholesalers in France. They have export licenses from Swiss authorities. They have import permits from French customs. everything is properly documented, stamped, signed and filed. The fact that the pharmaceutical wholesalers are often fronts for trafficking organisations, that the quantities being exported far exceed medical demand,

that the drugs are ultimately being diverted to illegal markets. None of this is visible in the paperwork. The paper trail shows legal commerce, and as long as the paperwork is in order, Swiss authorities are disinclined to investigate further. This is what we might call willful blindness as government policy. which is significantly more polite than calling it complicity, but amounts to roughly the same thing in practice. The Swiss weren't unique in this.

Several European countries hosted similar operations during this period, but Switzerland's combination of chemical expertise, permissive regulations, and strategic location made it a particularly important node in the heroin supply chain. The Swiss pharmaceutical industry was making substantial money from heroin production, both from legitimate medical sales and from grey-mobile. market exports that everyone understood were probably not entirely legitimate. The Swiss government was collecting tax revenue from this economic activity and apparently saw no particular reason to

scrutinise it too carefully. This was good business for Switzerland, and business concerns tended to trump drug control efforts, especially when the addiction problems were happening in other countries. Now let's follow the heroin from Switzerland to France, because the transportation and distribution networks are fascinating in their sophistication. The drugs would be packaged to look like legitimate pharmaceutical shipments, professional labelling, proper packaging materials, documentation declaring them as medical supplies. They'd be loaded onto trains or trucks and transported to France through normal commercial shipping channels. Customs officials at the border would see paperwork indicating this was pharmaceutical cargo, would note that everything appeared to be in order

and would wave it through. They weren't necessarily corrupt. They were. They were They were just processing enormous volumes of legitimate trade and didn't have the resources or mandate to carefully inspect every pharmaceutical shipment to verify that the contents matched the documentation. Some shipments went to legitimate pharmaceutical companies and pharmacies that were actually using the heroin for medical purposes as the paperwork claimed. But significant quantities were going to what appeared to be legitimate businesses but were actually fronts for trafficking operations. A pharmaceutical wholesaler might have an office, a warehouse, a warehouse,

even a few legitimate customers to maintain appearances. But most of their inventory would be diverted to illegal markets. The heroin would arrive with clean documentation showing it had been legally imported, at which point the documentation's usefulness ended, and the drugs could be distributed through whatever channels the organisation had established. The French ports Marseille, particularly, but also La Jave and other coastal cities, became crucial transfer points. Heroin arriving from Switzerland might be consolidated with other shipments,

and sent onward to international destinations, or it might be broken down into smaller quantities for domestic distribution. The ports had enormous volumes of legitimate trade passing through daily, which provided excellent cover for drug trafficking. A crate labelled as containing pharmaceutical supplies looked identical to thousands of other crates passing through the port. Unless customs officials had specific intelligence about a particular shipment, they had no reason to single it out for inspection.

Marseille developed a particularly notorious reputation as a heroin hub, which would later be romanticised in films like the French Connection. But in the 1920s, it was already functioning as a major node in international heroin trafficking. The city had the infrastructure ports, warehouses, transportation links to handle, large-scale smuggling operations. It also had a criminal underworld with the expertise and connections to manage distribution. The Corsican crime families that would later dominate French heres in trafficking were already active in the 1920s, though they weren't yet as organized or powerful as

they would become. They provided services that were valuable to traffickers, warehouse space that wouldn't attract official attention, transportation that wouldn't be scrutinized, connections to distribution networks in other countries, and most importantly, a code of silence that kept authorities in the dark about their operations. The organizational structure of these early trafficking networks is worth examining because they established patterns that would persist throughout the 20th century. At the top, you had executives and financiers, often respectable business people, with legitimate commercial operations who were investing in heroin trafficking as a side venture. They provided capital and business expertise but maintained distance from the actual drug operations.

Below them were logistics coordinators who managed the supply chain arranging for morphine purchases, coordinating laboratory production, organizing transportation, handling documentation. These were essentially supply chain managers who happened to be working in illegal trade rather than legitimate commerce. Then you had the middle management warehouse operators, transportation coordinators, local distributors. These people handled the actual movement and storage of drugs, but didn't make high-level decisions about operations. They followed instructions, solved logistical problems and kept things running smoothly. At the bottom were the street-level operators,

the people running the fronts that sold to users, the couriers moving small quantities, the muscle that provided security and handled disputes. This hierarchical structure insulated the top leadership from direct involvement in illegal activities. If low-level operators got arrested, they didn't know enough to implicate higher-ups. If a shipment got seized, the loss was absorbed,

and operations continued. This organisational structure also allowed for adaptive routing. If one smuggling route got compromised, or a particular border became more strictly controlled, the organisation could shift to alternative routes without disrupting the overall operation. Heroin that usually went through Marseilles could be rerouted through Le Havre. Shipments that normally moved by train could shift to truck transport.

The flexibility and redundancy built into the system made it remarkably resilient to law enforcement efforts. Taking down one distribution cell or seizing one shipment would barely impact the larger operation because there were always alternative channels. The networks also demonstrated what we might call corporate discipline, which sounds ironic when discussing criminal organisations, but was actually quite accurate.

These operations had hierarchies, standard operating procedures, quality control, financial accounting, and human resources practices that mirrored legitimate businesses. People who couldn't be trusted were removed sometimes violently, but often just fired like in any corporation. Employees who performed well were promoted and given more responsibility. Disputes between different parts of the organisation were resolved through negotiation or arbitration rather than immediately resorting to violence. This business-like approach made the

organisations more effective and more durable than the disorganised criminal gangs that people typically imagined. Financial operations were particularly sophisticated. Trafficking organisations needed to move large amounts of money across borders while avoiding detection by authorities. They developed techniques that would later be called money laundering, though that term wasn't commonly used yet. Profits from heroin sales would be mixed with revenue from legitimate businesses. Money would be transferred through multiple intermediaries to obscure its source. Transactions would be structured to avoid triggering reporting requirements. The financial operations required expertise in international banking, currency exchange and commercial law, which meant that trafficking

organisations employed or consulted with accountants, lawyers and financial professionals who provided their services while maintaining plausible deniability about the criminal source of the money they were handling. Let's talk about the documentation more, because this is really where the genius of the system reveals itself. The entire operation was clothed in legitimate paperwork. Every shipment had proper documentation, every facility had the required licenses, every transaction had corresponding financial records. If authorities investigated any individual component, they'd find what appeared to be legal commerce. The illegality only became apparent when you connected all the pieces and noticed that the volumes of drugs being produced vastly exceeded

medical demand. Or when you tracked shipments end-to-end and realized the final destinations weren't actually the medical facilities claimed in the paperwork. But making those connections required international cooperation, sophisticated intelligence gathering, and sustained investigative effort resources that law enforcement in the 1920s generally didn't have or didn't allocate to drug enforcement. Police in Switzerland didn't particularly care what happened to heroin after it left their country. French authorities weren't closely monitoring what pharmaceutical shipments were arriving from Switzerland. Customs officials were focused on collect. tax tariffs and preventing smuggling of untaxed goods, not on tracking legitimate pharmaceutical

commerce. The trafficking networks exploited these gaps systematically, using the machinery of legal international commerce to move illegal drugs. The scale of this operation was enormous. We're talking about tons, literally tons of heroin being produced and distributed annually through these networks. Some was consumed in France, which we've been discussing, but substantial quantities were exported to the United States, where heroin had been made illegal. in 1924. The American market was lucrative precisely because heroin was banned prohibition, created price premiums that made international smuggling highly profitable. French networks would supply American criminal organisations who would distribute domestically. The profits were staggering.

A kilogram of heroin that cost a few hundred dollars to produce in Switzerland could be sold for tens of thousands of dollars on American streets after being cut and packaged for retail. These profits created powerful incentives to maintain. and expand operations. Trafficking organisations reinvested their profits into growing their networks, bribing officials, developing new smuggling routes, and establishing additional front companies. The business was scaling up rapidly, becoming more sophisticated and more deeply entrenched with each passing year. By the mid-1920s, international heroin trafficking had evolved from opportunistic smuggling into organised criminal enterprise operated with business-like efficiency.

The corruption this generated was substantial, though often subtle. It wasn't primarily about police officers or customs officials taking direct bribes to look the other way, though that certainly happened. More often, it was about creating relationships and dependencies that compromised official integrity without obvious criminality. A pharmaceutical company that was a major employer in a small Swiss town and a significant contributor to local tax revenue could expect local authorities to be reluctant to investigate their operations too aggressive.

A shipping company that provided jobs and economic activity in Marseilles could count on port authorities not scrutinising their cargo too carefully. Politicians whose campaigns receive donations from business people connected to trafficking organisations would be disinclined to support aggressive drug enforcement that might harm their donor's interests. This web of economic interest and subtle corruption made the trafficking networks remarkably difficult to disrupt. Even when authorities wanted to crack down, they face political resistance from constituencies that benefited economically from the drug trade. Business groups would argue that pharmaceutical manufacturing was important industry that shouldn't be over-regulated. Labor unions would resist enforcement efforts that threatened jobs. Politicians would worry about economic impacts on their districts. The trafficking networks were embedded in the legitimate economy deeply enough that attacking them would cause collateral damage to innocent businesses and workers.

which created political complications that often paralysed enforcement efforts. International cooperation on drug enforcement was basically non-existent in any meaningful sense during this period. The League of Nations had established some frameworks for cooperation, but these were largely toothless. Countries would agree to control drug production and trade, but then interpret their commitments in ways that allowed them to continue profiting from the drug business. Switzerland would claim it was controlling pharmaceutical production, but declined to, investigate whether drugs were being diverted. France would assert it was monitoring pharmaceutical imports but not actually verify what happened to the drugs after

they entered the country. The United States would complain about drugs being smuggled from Europe but wouldn't provide the intelligence or resources that would have been necessary to actually intercept those shipments. The result was a situation where everyone could claim to be addressing the problem while nobody was actually doing much about it. Official statements would condemn drug trafficking. conferences would be held where representatives would express concern and pledge cooperation. Occasional arrests would be made and presented as evidence of aggressive enforcement. But the fundamental business of producing and trafficking heroin continued unimpeded

because no country wanted to bear the economic and political costs of truly aggressive enforcement. The irony is that most of this trafficking was unnecessary from a pure medical standpoint. The legitimate medical demand for heroin could have been satisfied with a fraction of the production that was occurring. But the pharmaceutical industry and trafficking networks had created a system where massive overproduction was extremely profitable, and the regulatory environment allowed this to continue under the guise of medical necessity. The economic incentives were all pointing toward producing more drugs, not fewer, and the regulatory systems that theoretically existed to control production were too weak or too compromised to counteract those incentives. Some historians argue that this

period represents the birth of modern drug trafficking as we understand it. Before the 1920s, illegal drug trade was mostly small-scale and disorganized, but the combination of emerging international prohibition, sophisticated pharmaceutical manufacturing capability, and the financial incentives created by legal-legal market gaps, catalyzed the development of large-scale, organized trafficking networks that operated across national boundaries with corporate-like efficiency. These networks established practices documentation fraud, money laundering, corrupt relationships with officials, adaptive routing, hierarchical organization that would be refined and expanded by subsequent generations of traffickers dealing in heroin, cocaine and other

drugs throughout the 20th century. The French connection that emerged in the 1920s would persist for decades. Even after France tightened regulations and the centers of heroin production shifted to other regions, the trafficking networks and expertise that had developed in France continued to play important roles in international drug trade. Marseille remained a crucial hub. French criminal organisations maintained their expertise in heroin trafficking. The methods pioneered in this era using legal pharmaceutical production as cover for illegal trafficking, exploiting regulatory gaps between jurisdictions, maintaining sophisticated international supply chains, became standard practice in drug trafficking globally. Looking at this system from our modern vantage point,

with the benefit of a century of experience with drug trafficking and enforcement, it's remarkable how thoroughly the basic architecture was established in this early period. The cat and mouse dynamic between traffickers and law enforcement, the use of legal business structures to disguise illegal activity, the corruption of officials through economic incentives rather than direct bribery, the international cooperation challenges that hamper enforcement. All of these are were present and apparent in the 1920s. The war on drugs that would later be declared was essentially fighting against organizational and operational models

that had been perfected decades earlier, the pharmaceutical companies that participated in this system were the knowingly or through willful ignorance established precedent for pharmaceutical industry involvement in creating addiction epidemics. The pattern would repeat with barbiturates in the 1940s and 50s, with prescription amphetamines in the 1960s, with benzodiazepines in the 1960s, with benzodiazepines in the 90s,

1970s and most notoriously with prescription opioids in the 1990s and 2000s. Each time pharmaceutical companies would develop and market highly addictive drugs, would downplay addiction risks, would resist regulation and would profit enormously while populations developed epidemic levels of addiction. The playbook was written in the 1920s with heroin and it's been reused repeatedly because it works and because the consequences for pharmaceutical companies are typically less severe than the profits they make before regulations finally catch up. The Swiss laboratory operations established that producing drugs in countries with permissive regulations and then exporting them to jurisdictions where they're illegal is a viable business model.

This would be repeated throughout history with various drugs and various countries. Methamphetamine production in Eastern Europe for Western European markets. Ventanil precursors manufactured in China and exported to Mexico. The specific drugs and countries change, but the basic model produce in permissive jurisdictions, traffic to restrictive ones remains constant. The corruption patterns established in this era also proved durable. The insight that you don't need to corrupt everyone, just create enough uncertainty and enough competing interest that enforcement becomes politically

and practically difficult, has been applied successfully by traffickers for a century. You don't bribe the whole police force. You just bribe key officers who can. provide intelligence and warning. You don't corrupt all politicians. You just contribute to enough campaigns that drug enforcement becomes politically risky. You don't own the banks. You just do enough legitimate business through them that they have incentives not to scrutinize your transactions too carefully. These techniques of selective corruption and economic entanglement were developed in the 1920s and remained fundamental to how organized crime operates today. The 1920s French heroin trade

also demonstrated that prohibition creates opportunities for organised crime that can actually strengthen criminal organisations and make drug problems worse rather than better. When drugs are legal but regulated, you get pharmaceutical companies making profits problematic in its own ways, but at least the money is flowing through legal economy. When drugs are prohibited, you get criminal organisations making those same profits, which they then used to corrupt officials, develop trafficking infrastructure, and expand into other criminal enterprises. The Prohibition experiment with heroin and other drugs essentially served as a massive subsidy to organized crime, providing the resources and incentives for criminal organizations to grow and professionalize. This lesson would be ignored

repeatedly throughout the 20th century, as politicians continued to believe that Prohibition would solve drug problems, despite mounting evidence that it tended to. to make them worse. The global supply chain that developed to keep Paris's pharmacies stocked with heroin was ultimately a preview of how globalization would facilitate both legal commerce and illegal trafficking. The same infrastructure that allowed legitimate goods to move efficiently across borders standardized shipping containers, international banking systems, legal frameworks for commercial documentation also facilitated illegal trade. The more connected and efficient the global economy became, the easier it was for criminal organizations to exploit that connectivity for trafficking

purposes. This remains true today, as global supply chains for everything from electronics to pharmaceuticals to illegal drugs all use the same basic infrastructure and face similar challenges around verification and enforcement. The shift from legality to prohibition didn't happen gradually with careful consideration of how to manage the thousands of people who've been legally using heroin for years. No, that would have required forethought and compassion. Qualities that political systems responding to moral panic rarely demonstrate. Instead, what happened was closer to flipping a light switch medicine one day, felony the next, with absolutely no transition plan for the people caught in between. This is a masterclass in how not to handle a public health crisis, and the

consequences were predictably catastrophic in ways that should have been obvious to anyone paying attention but apparently weren't. The international pressure for drug prohibition had been building throughout the early 1920s. The United States, having gone full-temperant zealot with alcohol prohibition, and discovering that banning things doesn't make them go away, but does make them more profitable for criminals, decided the solution was to ban more things. American diplomats pushed aggressively for international drug control agreements.

The League of Nations, eager to demonstrate it, could coordinate international action on something after failing to prevent wars, focused significant attention on drug control as an achievable goal that wouldn't require actually stopping countries from invading each other. France had been resistant to prohibition initially, partly because French culture tends towards skepticism of absolute bans on substances, and partly because the pharmaceutical industry was making excellent money from heroin production and didn't want that revenue stream interrupted.

But by the mid-1920s, the domestic addiction problem was becoming too visible to ignore, international pressure was intensifying, and French politicians decided they needed to be seen doing something decisive about the drug crisis. What they decided to do was ban heroin entirely, with minimal warning and essentially no support systems for the thousands of addicted people who'd been obtaining their drugs legally from pharmacies the previous week. The law went into effect on a Tuesday in November 1925. I'm making up the specific date because the exact timing varies depending on which regulation you're discussing. But the sudden is historically accurate. On Monday, you could walk into a pharmacy and purchase heroin preparations

legally, the same as you'd been doing for months or years. On Tuesday, attempting to do the same thing was a criminal act that could result in arrest and imprisonment. The medicine that doctors had been prescribing as appropriate therapy for various conditions was now classified as having no legitimate medical use. The patients who'd been following medical advice were suddenly criminals, for continuing to do exactly what they'd been told was proper health. care. Let's follow Marguerite again. Remember her, our secretary from the 11th arrondissement, who we last saw deep in addiction. She'd been taking heroin daily for nearly two years by the time prohibition hit. Her physical dependence was complete. Missing a single dose would trigger withdrawal

symptoms severe enough that she couldn't function. She'd structured her entire life around maintaining her supply multiple pharmacy visits, careful rationing, significant portions of her income devoted to purchasing drugs. She wasn't thriving, but she'd achieved a kind of desperate equilibrium where she could mostly keep things together as long as she had access to heroin. Exema is unpredictable, but you can flare less with ebbglis, a once-monthly treatment for moderate disappear eczema. After an initial four-month-month-longer dosing phase, about four and ten people taking ebbglis achieved itch relief and clear or almost clear skin at 16 weeks, and most of those people maintain skin that's still more clear at one year with monthly dosing.

Ebglis, Librikizumab LBKZ, a 250 milligram per 2 milliliter injection is a prescription medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds or 40 kilograms with moderate to severe eczema. Also called atopic dermatitis that is not well controlled with prescription therapies used on the skin or topicals or who cannot use topical therapies. Ebglis can be used with or without topical corticosteroids. Don't use if you're allergic to ebbglis. Allergic reactions can occur that can be severe. Eye problems can occur. Tell your doctor if you have new or worsening eye problems. You should not receive a live vaccine when treated with Ebbglis.

Before starting Ebbglis, tell your doctor if you have a parasitic infection. Ask your doctor about Ebbglis.com or call 1800 lilyrx or 1-800545-9709. The day the ban takes effect, she goes to her usual pharmacy with a prescription from her doctor. The pharmacist, whom she's been seeing weekly for months, looks uncomfortable and explains that he can no longer sell heroin products under any circumstances. The law changed. She should speak with her doctor about alternative treatments. He's sorry. Marguerite starting to feel the early edges of withdrawal after not taking her morning dose asks what she's supposed to do. The pharmacist doesn't have an answer. He's just following the

new regulations. He suggests perhaps she should try going without. A lot of patients have been managing fine, he claims, which is either a lie or wishful thinking because managing fine and experiencing severe opioid withdrawal are mutually exclusive states. She tries to two more pharmacies. Same story. Nobody will sell to her. Nobody has been given information about how to help patients transition off heroin. Nobody seems to understand that you can't just stop taking opioids cold turkey after years of daily use without experiencing medical consequences. Or if they understand it, they've been given no guidance about what to do with that knowledge. The government's position appears to be that heroin was bad and now it's banned and anyone

who is using it should just stop, as if addiction were a simple matter of making better choices rather than a complex physiological condition requiring medical management. By that evening, Marguerite is in full withdrawal. She's sweating despite the November cold. Her muscles ache like she's been beaten. She's nauseous but can't eat. She's alternating between feeling feverish and feeling chilled. She can't sleep but can't stay awake. Her anxiety which heroin had been suppressing for two years returns with a vengeance amplified by the physical distress of withdrawal. She spends the night. She spends the night. in absolute misery, genuinely believing she might die, and almost wishing she would because

death would at least end this suffering. This same scene replicated across Paris and across France. Thousands of people who'd been legally using heroin suddenly found themselves cut off with no medical support, no transition plan, no gradual tapering protocol. The government had decided to solve the addiction problem by eliminating legal supply without apparently considering what would happen to the addicted population. It's the kind of policy that sounds decisive and tough when announced at a press conference, but becomes humanitarian disaster when actually implemented. The immediate mortality spike was substantial, though exact numbers are difficult to determine, because cause of death reporting in 1995 wasn't particularly sophisticated, and deaths related to drug withdrawal often got attributed

to other causes. Some people died directly from the physiological stress of withdrawal cardiac complications, seizures, dehydration from vomiting and diarrhea. Opioid withdrawal itself is rarely fatal in healthy adults, but many of these users weren't healthy adults. They'd been malnourished, stressed, and physically compromised by years of drug use. Throwing them into severe withdrawal without medical supervision was dangerous, and some didn't survive it. More died from complications of rapid detox attempts.

Some doctors, faced with desperate patients in withdrawal, tried to manage the situation medically, but didn't have good protocols because addiction medicine basically didn't exist as a specialty. They might prescribe sedatives that interacted badly with the patient's compromised physiology. They might recommend hydration strategies that were inadequate. They might attempt rapid tapering with remaining pharmaceutical opioids, but these supplies were themselves being restricted, and the tapers were too fast and patients ended up suffering withdrawal anyway. Medical care during this transition period was often well-intentioned but poorly informed and the outcomes reflected that unfortunate combination. Then there were the suicides. Opioid withdrawal

include severe depression as a symptom. Take someone who's already struggling psychologically, throw them into acute withdrawal with its attendant physical agony and psychological despair, remove their coping mechanism that's been keeping them functional and provide no alternative support, and you create conditions where suicide becomes a genuine risk. The suicide rate among former heroin users spiked in the months following prohibition. Some were impulsive acts during the worst of acute withdrawal. Others were more calculated decisions by people who'd attempted to quit, discovered they couldn't bear life without heroin, and chose death over continuing to suffer. But the largest category of excess deaths came from the shift to illegal markets with their unpredictable quality

control. Because here's the thing about prohibition. It doesn't eliminate demand. It just redirects that demand to illegal suppliers. All those thousands of people who'd been buying heroin from pharmacies still needed heroin. Their physical dependence didn't vanish when the law changed. So they turned to the illegal market that emerged immediately to service that demand because markets are remarkably efficient at appearing wherever there's unmet demand and potential profit. The illegal heroin that became available after prohibition was funded. fundamentally different from the pharmaceutical heroin people had been using. Pharmaceutical heroin had consistent purity.

You knew what concentration you were getting, which meant you could dose accurately and relatively safely. Illegal heroin had wildly variable purity, depending on who'd produced it, what they'd cut it with, and how many intermediaries it had passed through before reaching the end user. A dose that worked fine last week might be twice as concentrated this week, because it came from a different source, and that variability killed people through overdose.

Contamination was another issue. Pharmaceutical heroin was produced in sterile conditions with quality control. Illegal heroin was produced in clandestine labs with whatever precursors and equipment the manufacturers could obtain under conditions where sterility was a distant consideration compared to avoiding detection. The final product might contain residual chemicals from the manufacturing process. Adulterants added to increase volume and profit, or contamination. from unsanitary conditions. People developed infections, toxic reactions and mysterious ailments from consuming drugs that were pharmacologically active but medically unsafe. The cutting agents used to dilute

heroin introduced additional risks. Illegal suppliers would mix heroin with various substances to increase volume and profit margin lactose, quinine, talcum powder, whatever was available and looked similar to heroin powder. Some cutting agents were relatively inert and just reduced potency. Others were actively harmful. Quinnon could cause synchonism ringing in ears, vision problems, cardiac issues, talc could be aspirated into lungs or cause vascular problems if injected. Users had no way of knowing what they were actually consuming, turning every dose into a gamble with their health. Dosing became a nightmare of uncertainty. Someone who'd been taking a specific amount of pharmaceutical heroin to maintain their addiction, without getting too impaired, would try to use the same amount of illegal heroin,

and discover it was either too weak, leaving them in withdrawal or too strong, producing dangerous intoxication or overdose. There was no way to calibrate doses accurately. You were essentially guessing, adjusting based on effects, and hoping you didn't guess wrong in a way that killed you. This is not an exaggeration illegal opioid. Markets kill people primarily through overdose from unpredictable potency, a pattern established in the 1920s that continues today.

The social infrastructure that had made drug use relatively stable also collapsed with prohibition. Those jazz clubs were musicians and patrons used together, raided by police and shut down, those artistic studios in Monmart where people would gather, under surveillance and subject to arrest if drugs were found. Those elegant salons where wealthy women administered their medicine with silver syringes, forced underground or abandoned entirely. The spaces where drug use had been occurring with some degree of social, oversight and harm reduction, not intentional harm reduction, but at least people were using together. Someone could get help if things went wrong, those spaces disappeared, replaced by

isolated clandestine use in circumstances where overdoses were more likely to be fatal because nobody was around to intervene. The community knowledge about safer drug use also fragmented. In the semi-legal environment before prohibition, users could share information relatively openly. This pharmacy has cleaner products. That preparation is too strong for beginners. If you're going to inject, here's how to do it more safely. This informal knowledge transfer helped reduce harms. After prohibition, drug use became more secretive.

New users couldn't access the accumulated wisdom of experienced users. Dangerous practices spread because there was no community mechanism for correcting them. People made preventable mistakes because they couldn't ask questions without risking exposure as drug users and potential arrest. Law enforcement during this period was spectacularly ineffective at reducing drug use but highly effective at making users' lives worse. Police would arrest people for possession of small amounts of heroin, the amounts consistent with personal use rather than dealing, and those arrested would face criminal prosecution, imprisonment, criminal records that destroyed employment prospects. The arrest didn't address the underlying addiction. People would serve time, be released, still be addicted, and immediately returned.

turn to using. But now they'd have criminal records that made rebuilding their lives even more difficult. The criminal justice approach to addiction was creating criminals out of sick people without doing anything to address the sickness. Dealers and traffickers faced enforcement too, but they were better positioned to avoid consequences. They had resources for bribes and lawyers. They used intermediaries and compartmentalized operations so that arrests of low-level sellers didn't compromise the larger organisation. The trafficking networks we discussed earlier adapted to prohibition by becoming more sophisticated and more violent. They had to secure their illegal market positions through methods that legitimate pharmaceutical companies didn't need. Intimidation, violence, corruption.

Prohibition transformed drug markets from commercial enterprises into criminal operations, with all the attendant violence and social harm that criminality entails. The medical establishment was caught in an impossible position. Doctors had patients who were genuinely suffering from opioid addiction, but they had no legal tools to help them. They couldn't prescribe heroin for addiction because it was now banned for all purposes. They didn't have effective alternative treatments. Methadone wouldn't be developed for decades, and other medication-assisted treatments were similarly far in the future. The best they could offer was moral support and advice to quit, which was roughly as useful as advising someone with a broken leg to walk more carefully.

well-intentioned, perhaps, but not actually addressing the medical problem. Some doctors tried to help anyway, writing prescriptions for other opioids that weren't yet banned, or providing prescriptions for sedatives to ease withdrawal symptoms, or even quietly continuing to prescribe heroin through various subterfuges. These efforts put them at risk of prosecution for facilitating drug use. The law made no distinction between a doctor trying to help a patient manage addiction and a criminal selling drugs for profit. Both were a legal distribution of prohibited substances.

Some doctors were prosecuted and lost their licenses. Others stopped trying to help addicted patients because the legal risks were too high. The result was that the medical system, which should have been part of the solution, was largely absent when patients needed it most. Hospitals faced similar challenges. Emergency rooms saw an influx of patients suffering from opioid withdrawal, overdose, and complications from illegal drug use. The medical staff wanted to help but had limited options.

They could manage acute symptoms, rehydrate someone, stabilize someone who'd overdosed, treat infections. But they couldn't address the underlying addiction with medication because that would require prescribing substances that were now illegal. They'd treat the immediate crisis, discharge the patient and know with near certainty that the patient would be back soon with similar problems because nothing had actually been resolved. The psychiatric establishment also struggled to respond effective

Many addicted patients were experiencing severe depression, anxiety and other mental health issues, some pre-existing, some resulting from addiction and withdrawal. Psychiatrists wanted to provide therapy and support, but talk therapy isn't particularly effective for managing acute opioid withdrawal, and they didn't have pharmaceutical tools to address the immediate physical and psychological distress. Some psychiatrists advocated for more humane approaches to addiction for treating it as a medical condition rather than a criminal matter, but they were swimming against a strong political current toward criminalisation and moral condemnation of drug users. The social services that existed, which were minimal in 1925 compared to modern

welfare states, were similarly overwhelmed and under-equipped. Charitable organisations tried to help. Churches offered support. But these institutions were set up to address poverty and moral reformation, not medical addiction. Their help often came with moral judgment. You could get assistance if you demonstrated you were truly repentant and committed to quitting, which is great except addiction doesn't work that way. You can be genuinely committed to quitting and still relapse repeatedly because addiction is a chronic brain disease, not a moral failing that resolves through sufficient commitment and prayer. The family disruption caused by prohibition's sudden implementation was extensive. Addicted individuals who'd been maintaining some functionality through legal

pharmaceutical heroines suddenly couldn't work, couldn't care for children, couldn't fulfill basic obligations because they were either in withdrawal or desperately seeking illegal drugs. Families disintegrated under the stress. Children were placed in orphanages or with relatives. Marriages dissolved. Elderly parents who'd been depending on addicted adult children for care found themselves without support. The social fabric that holds communities together was being shredded by a policy that was supposed to protect public health, but was actually destroying it. The economic impact on families was particularly devastating. Legal pharmaceutical heroin had been expensive but somewhat predictable in cost. Illegal heroin was even more expensive and prices

fluctuated wildly based on supply and enforcement pressure. Families that had been allocating significant but manageable portions of their income to purchasing drugs found themselves unable to afford the illegal market prices. This created impossible choices. Feed your children or buy drugs to stave off withdrawal, pay rent or maintain your addiction. Some families chose drugs and ended up homeless. Others chose basic necessities and the addicted family member suffered through withdrawal or died. Neither outcome was acceptable, but Prohibition forced these choices on thousands of families. The criminal element that entered family life was also destructive. When your family member needs drugs, and the only source is illegal dealers, you become entangled

with criminal networks. Maybe you're providing money that's going to organise crime. Maybe your home is being used as a storage or distribution point. Maybe you're being pressured to participate in illegal activities to pay off drug debts. Prohibition transformed what had been a medical issue into a criminal one, and that criminalisation contaminated everything it touched, spreading beyond the individual user into their entire social network. The public health infrastructure of 1920s Paris was completely unprepared for this crisis. There was no concept of harm reduction, no needle exchanges, no safe injection sites, no overdose prevention programmes. These ideas were decades away from being developed and implemented. The public health approach was abstinence only,

just stop using drugs, with no acknowledgement that this was unrealistic for most severely addicted individuals and provided no support for the difficult process of actually achieving and maintaining abstinence. The predictable result was that public health outcomes worsened dramatically after prohibition was implemented. Disease transmission increased because illegal drug use was more likely to involve sharing of injection equipment. Pharmaceutical heroin users might have had their own syringes, purchased legally and used in relatively hygienic conditions. Illegal drug users were using whatever equipment was available, often sharing needles among groups, spreading infections.

Hepatitis and other blood-borne diseases started circulating through the drug using population at higher rates. HIV wouldn't appear for decades, but when it did, it would spread through these same roots that prohibition had made more dangerous. Overdose deaths, as we've mentioned, increased substantially. But the nature of overdoses also change. Pharmaceutical overdoses, when they occurred, usually happened in circumstances where the person could receive medical attention. You'd overdose at home. Someone would find you. They'd call a doctor. Maybe you'd survive, maybe not, but you had a chance. Illegal drug use happened in more isolated, secretive circumstances. You'd overdose alone in a room, in an alley, in a place where nobody would find you for hours or days.

The mortality rate from overdoses was higher because the response time was slower, and help was less available. The irony of prohibition is that it was intended to reduce drug-related harm, but demonstrably increased it across virtually every metric. Drug use didn't decrease studies from the period suggests that consumption either remained steady or actually increased slightly after prohibition, as forbidden fruit became more appealing, and criminal organizations marketed aggressively to maintain their customer base. But the harms associated with drug use absolutely increased. More deaths, more disease, more crime, more family disruption, more social problems. Prohibition transformed a managed public health crisis into an unmanaged humanitarian disaster.

The political response to this disaster was to insist that the problems were evidence that prohibition wasn't being enforced aggressively enough. Politicians who'd supported the ban pointed to the suffering and chaos and argued this showed that drug use was even more dangerous than they'd thought, justifying more police resources, harsher penalties, and more aggressive enforcement. The possibility that prohibition itself was causing many of these problems was rarely considered because that would require admitting the policy had been a mistake, and politicians are remarkably reluctant to admit mistakes when they can instead double down on failed approaches.

Some voices did argue for more humane approaches. A few doctors, social workers and progressive reformers pointed out that criminalising addiction was counterproductive, that medical treatment would be more effective than imprisonment, that harm reduction strategies could save lives even if they didn't immediately eliminate drug use. These voices were largely ignored or dismissed as being soft on crime, as enabling addiction, as failing to understand the moral dimensions of drug use. The political climate was punitive, not compassionate, and policies reflected that orientation. The international dimension of prohibition also created perverse effects. As France cracked down on domestic heroin

supply, French trafficking organisations simply redirected their operations to focus more on export markets. The same laboratories and distribution networks that had been supplying French pharmacies continued producing heroin, now shipping it primarily to other countries where it could be sold at higher prices on illegal markets. So French prohibition didn't reduce global heroin supply, it just shifted where that supply was consumed and increased the price by making distribution more difficult and risky. The American market became particularly important for French traffickers after prohibition. Americans were paying premium prices for illegal heroin, creating powerful incentives for trafficking organisations to establish transatlantic smuggling routes. The French connection

that would become famous in the 1960s had its origins in this period, when French laboratories and Corsican crime families established themselves as primary suppliers to American markets. American Prohibition created a profit opportunity that French criminal organizations were happy to exploit, generating enormous profits that they used to corrupt officials, expand operations, and entrench themselves in both countries. Looking back, it's difficult to find anyone who benefited from heroin Prohibition as implemented in 1920's Paris. Users suffered through withdrawal and entered dangerous illegal markets. Families were destroyed by the sudden loss of legal supply and the criminalisation of their loved ones. The medical establishment was prevented from helping

patients and struggled with a crisis they weren't equipped to address. Law enforcement became overwhelmed with prosecuting users while trafficking organisations grew more powerful. The public health system saw outcomes worsen across virtually every indicator. Society as a whole absorbed enormous costs, medical costs from worse health outcomes, criminal justice costs from enforcement and prosecution, social costs from family disruption and community destruction. The only clear winners were the criminal organisations that captured the illegal market and the politicians who could campaign on being tough on drugs, regardless of whether their policies actually improved anything. The traffickers made vast fortunes. The politicians won elections. Everyone else paid the price for a policy that was

designed to solve a problem, but actually made it dramatically worse. This pattern of prohibition policies that increase harm while claiming to reduce it would be repeated throughout the 20th century with various drugs in various places. The lesson was available to be learned from Paris in the 1920s, but it wasn't learned, or at least not learned well enough to prevent the same mistakes from being repeated again and again. Just when you thought the situation couldn't get worse, and really, prohibition had already set a high bar for making things worse. Along came October 1929 and the global economic collapse that would turn an existing drug crisis into something approaching apocalyptic.

The Great Depression hit everyone hard, but it hit addicted populations with particular brutality because their already precarious existence depended on having enough money to purchase drugs from expensive illegal markets. When that money disappeared, when jobs evaporated and savings were wiped out and social support systems collapsed under overwhelming demand, the drug-using population found itself trapped between the rock of addiction

and the hard place of absolute poverty. The combination was lethal, sometimes literally. Before the crash, the illegal heroin market in Paris had at least been somewhat functional. Yes, it was more dangerous than the pharmaceutical market had been. Yes, prices were higher and quality was variable. But if you had money, you could usually find drugs. Dealers needed customers, customers needed drugs, and the market cleared at some price point. It wasn't good, but it worked after a fashion. Then suddenly millions of people had no money,

or at least dramatically less money than they'd had before. Unemployment in Paris spiked. Businesses collapsed, wages for those still employed were slashed. The economic foundation that had been supporting people's drug habits simply disintegrated. For addicted individuals trying to maintain their habits through the depression, the mathematics became impossible. Let's return to Marguerite one final time. She'd survived the initial shock of prohibition, found illegal suppliers, and managed to continue using despite the increased costs and risks. By 1929, she'd lost her secretarial job. Her performance had declined too much to justify keeping her employed, but she'd found work as a seamstress, doing piecework at home. The pay was terrible, but it was enough to survive and to maintain a

minimal heroin habit that kept withdrawal at bay, even if it didn't provide much pleasure anymore. The depression destroyed even that meagre equilibrium. The demand for her sewing work dried up. Nobody was buying new clothes when they could barely afford food. Her income dropped to almost nothing. She sold what few possessions had value. She borrowed from family members who themselves were struggling. She delayed paying rent until her landlord threatened eviction, and still the physical dependence remained. Demanding. satisfaction regardless of her financial situation. Her body didn't care that the global economy had collapsed. It just knew that it needed heroin and would make her absolutely miserable until that

need was met. This scenario replicated across thousands of addicted people in Paris and across the world. The depression transformed drug addiction from a serious problem into an existential crisis for huge portions of the drug-using population. People who'd been barely managing before were now completely unable to maintain their habits through legal income. This created pressure toward increasingly desperate measures. Property crime increased as addicted people stole to fund their drug purchases. Prostitution increased as people commodified their bodies because they had nothing else left to sell. Violence increased as competition for scarce resources intensified and as people became willing to take greater risks to obtain money or drugs. The illegal drug market itself transformed under

depression conditions. Dealers, facing a customer base with dramatically reduced purchasing power, had to adapt their business models. They couldn't simply maintain pre-depression prices because customers couldn't pay them. You can't extract money people don't have, no matter how much they need your product. So dealers adjusted by cutting drugs more heavily, reducing purity to maintain profit margins while lowering absolute prices. A bag that cost the same as before, the depression might contain half as much actual heroin, diluted with whatever cutting agents were cheap and available. This created a vicious cycle of declining quality and increasing risk. Users needed more product to achieve the same effect because purity was lower,

but they had less money so they could afford less product. They'd end up underdosing, experiencing withdrawal, suffering. When they finally did acquire drugs, they might overcompensate by using too much, particularly if a batch happened to be less heavily cut than what they'd been using. The variability and quality that had been problematic before prohibition became genuinely deadly during the Depression because users couldn't afford to waste drugs testing potency carefully. They needed to use what they had and hope it didn't kill them.

The innovations in substitute drugs during this period were horrifying examples of what happens when addicted people become desperate and unscrupulous. People see profit opportunities. When heroin became too expensive, people turned to alternatives, and by alternatives, we mean increasingly dangerous substances that might provide some opioid effect but came with additional serious risks. Opium itself saw a resurgence, not the refined pharmaceutical preparations, but crude opium smoking or eating. This was cheaper than heroin, but also less predictable in potency, and more likely to contain contaminants. Some people turned to morphine extracted from other sources

through amateur chemistry, using whatever precursors they could obtain. These basement chemists weren't exactly following best practices in pharmaceutical synthesis. They were mixing chemicals in unsanitary conditions using incomplete knowledge and improvised equipment. The results were products of wildly variable potency that might or might not actually contain significant amounts of opioids and almost certainly contained various toxic byproducts from the synthesis process. People consume these concoctions anyway because withdrawal is terrible and any chance of relief seems worth the risk. Even more disturbing were the completely novel substances people tried when opioids became unaffordable. Industrial chemicals that had some sedative or analgesic properties got repurposed

as drugs of abuse. Solvents, paint thinners, various products never intended for human consumption. People experimented with inhaling or ingesting these substances, seeking any kind of altered consciousness that might temporarily relieve their psychological and physical suffering. The health consequences were catastrophic. Organ damage, neurological problems, poisoning, death. All became more common as people consumed increasingly dangerous substances in increasingly desperate attempts to manage addiction they couldn't afford to treat properly. The authority's response to this chemical Russian roulette

was to criminalise the new substances and arrest people for possessing or using them, which was exactly as effective as it sounds. You can make a substance illegal, but you can't make desperate people less desperate through prohibition. They'll just find something else, probably something even more dangerous because the safer alternatives have already been banned or are too expensive. The criminal justice system was creating a pharmacological arms race, where each new control measure prompted users to adopt something novel, and often more harmful, in an endless cycle that increased harm without reducing use. The medical system was overwhelmed to the point of collapse in dealing with complications. from the substitute drugs. Emergency rooms saw patients poisoned by substances

doctors had never encountered, presenting with symptoms that didn't match any textbook description because the patient had consumed some improvised chemical cocktail nobody had studied. Treatment was often guesswork. Some patients survived. Many didn't. The medical staff did their best but were handicapped by lack of knowledge,

lack of resources, and the sheer volume of cases that exceeded their capacity to respond. The Depression also intensified the criminalisation of poverty in ways that particularly harmed drug-using populations. When you're poor during economic good times, society might offer some grudging assistance or at least tolerance. When everyone's poor during a depression, society becomes much harsher about distinguishing between the deserving poor, who are suffering through no fault of their own, and the undeserving poor whose poverty is attributed to moral failings. Drug users were firmly categorised as undeserving. Their poverty was their own fault for being addicts.

They deserved no help, only punishment for their bad choices. This moral classification had real policy consequences. Whatever limited social services existed, soup kitchens, charitable aid, public relief programs, often explicitly excluded known drug users or people with criminal records from drug offences. The logic was that scarce resources should go to people who hadn't brought poverty on themselves through vice.

The result was that the most vulnerable people, those facing both addiction and poverty were systematically excluded from whatever safety net existed. They were told to get clean first, then they could receive help, which is precisely backwards if you understand that addiction is a medical condition that requires treatment and that poverty makes treatment nearly impossible to access.

The employment prospects for recovering addicts, never good, became essentially non-existent during the Depression. Even people without any history of drug use were struggling to find work. someone with visible track marks, deteriorating health, a criminal record from drug arrests. They had zero chance of competing successfully for scarce jobs. This created a class of people who were effectively permanently unemployable, not because they lacked ability, but because their drug use history marked them as

unworthy of employment in the eyes of potential employers. Without legal income opportunities, they had no choice but to engage in illegal activities to survive, which further cemented their status as criminals and made any kind of of rehabilitation or reintegration into normal society increasingly impossible. The concept of unable to work without treatment emerged during this period, though it wouldn't be formalised in those terms for decades. Medical professionals observing the drug using population noticed that many were capable of work. They had skills, experience, even strong work ethics, but were completely unable to function in employment while addicted or experiencing withdrawal.

give them stable access to their drug of dependence, and they could hold jobs and be productive, force them into abstinence without support, and they couldn't work. This observation would eventually inform medication-assisted treatment approaches like methadone maintenance, but in the 1930s it just meant that thousands of people were trapped in a state where they couldn't work because they were addicted, but they couldn't address their addiction because they had no money from not working. Families during the Depression faced impossible choices multiplied by addiction, Before the crash, a family might have been able to support an addicted member, providing housing and food while the person struggled with their drug use.

During the Depression, families could barely support themselves, let alone someone who wasn't contributing economically and might be stealing from family members to fund their habit. Many families made the agonising decision to cut off addicted relatives entirely, kick them out, refuse further financial support, sever contact. This was often presented as tough love, forcing the addict to hit bottom and finally get clean. In practice, it usually just meant consigning someone to homelessness and a significantly increased risk of death. The mortality rate among drug users during the Depression was substantially higher than in the general population. Exact statistics are difficult to obtain, but anecdotal evidence from hospitals, morgues and social service agencies suggest that addicted people were dying at rates several times higher than would be expected based on age and demographics. Some deaths were directly drug-related overdoses, poisoning from

substitute substances, infections from unsanitary injection practices. Others were from conditions exacerbated by drug use and poverty pneumonia, tuberculosis, malnutrition, exposure. The combination of addiction, poverty, and social exclusion created a perfect storm of mortality risk. The Depression also revealed the extent to which the drug crisis was stratified by class. Wealthy addicts, while certainly affected by economic downturn, usually maintained enough resources to continue accessing drugs. They might have reduced their consumption or shifted to less expensive preparations, but they rarely ended up on the streets or died from using industrial chemicals as drug substitutes. Their addiction was managed privately, with

complicit doctors providing prescriptions for remaining legal opioids or with connections to higher quality illegal supplies. The worst effects of prohibition and depression fell on poor and working-class drug users who lacked resources to buffer themselves from the crisis. This class dimension reinforced the perception of drug use as a problem of moral failing among the poor rather than a medical condition that could affect anyone. When wealthy people were addicted, it was tragic and required medical care and discretion. When poor people were addicted, it was predictable and required criminal justice intervention. The same behaviour interpreted completely differently based on the social class of the person engaging in it. This double standard was nothing new. It had been present since the

beginning of drug prohibition, but the depression made it more visible and more consequential, because the gap between how different classes experienced the drug crisis widened dramatically. Now we need to examine how this Parisian catastrophe influenced international drug policy, because the lessons that policymakers drew from Paris's experience were almost uniformly wrong, but were exported globally and shaped drug policy for the next century. The League of Nations, in its quest to coordinate international drug control, looked at Paris and saw confirmation that drugs were dangerous and required strict prohibition. They somehow missed that many of the worst harms were caused by prohibition itself rather than by drug

use per se. Or if they noticed this, they decided it was an acceptable price to pay for maintaining moral standards around drug abstinence. The diplomatic correspondence between nations in the late 1920s and early 1930s is fascinating for what it reveals about how policymakers thought about the drug problem. French officials would send reports to the League of Nations documenting the ongoing crisis mortality rates, crime statistics, economic impacts. These reports were meant to demonstrate that France was taking the drug problem seriously and implementing aggressive enforcement measures. But they were read by officials in other countries as evidence that drugs were even more dangerous than previously thought, justifying even stricter controls and more punitive approaches.

Nobody seemed to ask the obvious question. If Prohibition was working, why were all these terrible outcomes continuing or worsening? The logical inference would be that Prohibition wasn't working, that perhaps a different approach was needed. But that inference would be that, inference was politically impossible because it would require admitting that the international drug control regime that had been constructed with such effort was fundamentally flawed. So instead, the interpretation was that enforcement wasn't harsh enough, that countries needed to be more aggressive about punishing drug use and trafficking. The policy response to prohibition's failures was always more prohibition, stricter enforcement, harsher penalties. The Paris model of drug

control-strict prohibition, criminal penalties for possession and use, aggressive law enforcement targeting users and dealers, was held up as the example that other nations should follow. Never mind that it was producing catastrophic outcomes in Paris itself. The model was theoretically correct, policymakers insisted. If implementation in Paris had problems, that just meant implementation needed to be improved, not that the underlying model was flawed. This reasoning is remarkably common in policymaking. When reality, Reality contradicts your theory, declare that reality is wrong rather than questioning your theory. Other European nations adopted similar prohibition frameworks, often explicitly citing the French

example as justification. Each implementation brought its own disasters, addiction didn't respond well to criminalization regardless of which country was doing the criminalizing. The United States had already gone down this path and was experiencing similar problems. The international drug control consensus that emerged in the 19th, 30s, and would persist for decades, was built on a foundation of systematically misinterpreted evidence and policies that demonstrably increased harm while claiming to reduce it. The League of Nations Drug Control mechanisms were theoretically about international cooperation to reduce drug production and trafficking, but in practice, they were about exporting a

particular punitive model of drug control globally. The conventions and treaties that were negotiated essentially required signatory nations to criminalise drug use, and implement enforcement measures similar to what France and the United States were doing. Countries that might have preferred different approaches, medical treatment, harm reduction, regulated legalisation, found themselves pressured to conform to the international consensus on prohibition. The export of the punishment model was particularly harmful in colonised regions, where European powers imposed drug prohibition as part of their civilising mission, disrupting traditional uses of various substances and creating new criminal markets and enforcement problems.

The global drug control regime that emerged in the 20th century was deeply entangled with colonialism, racism and cultural imperialism, European and American powers dictating to the rest of the world what substances were acceptable and imposing their preferred policy approaches regardless of local contexts or preferences. But there was another strand of thinking emerging from the Paris experience, quieter and less politically influential, but ultimately more important for genuinely addressing addiction. A few physicians, social workers and researchers who'd been working directly with addicted populations during the crisis came to very different conclusions than the policymakers. They recognised that addiction was a medical condition requiring medical treatment,

not a moral failing requiring punishment. They saw that prohibition increased harm rather than reducing it. They began developing ideas that would eventually, become medication-assisted treatment and harm reduction. The concept of maintenance therapy providing addicted people, with legal access to opioids in controlled settings to stabilize their lives and reduce harm emerged partly from observing what happened when legal access was abruptly removed. Doctors noticed that patients who'd been functioning reasonably well while accessing pharmaceutical heroin had deteriorated rapidly after prohibition. The logical inference was that

maintaining stable access to opioids, while not ideal for, from an abstinence perspective might be superior to forcing people into illegal markets or unsuccessful withdrawal attempts. These ideas were deeply controversial and politically unpopular. They seemed like surrender, like giving up on getting people clean and instead enabling continued drug use. The moral framing of addiction is something that required complete abstinence, with any drug use being failure-made maintenance approaches, seem like accepting defeat. But the doctors and researchers advocating for these approaches weren't being defeated. they were being pragmatic. They recognised that for many severely addicted people, abstinence was

unrealistic in the short or even medium term, and that maintaining stability through controlled drug access produced better outcomes than forcing people into chaotic illegal drug use. The family trauma created by the heroin epidemic of the 1920s and its prohibition-driven catastrophe rippled through generations. Children who grew up in households affected by addiction carried that trauma into their adult lives. They'd witnessed parents or siblings destroyed by drugs. They'd experienced the poverty and instability that addiction created. They'd absorbed the message that drugs were dangerous

and that drug users were criminals or moral failures. This generational trauma influenced attitudes toward drugs and drug policy for decades. Some of these children became fierce anti-drug advocates, determined that others wouldn't experience what they'd experienced. Their advocacy was often rooted in genuine concern and real suffering, but it sometimes manifested as support for punitive policies that actually made drug problems worse. The trauma of growing up around addiction created emotional certainty that drugs were evil and needed to be eliminated at any cost, even when evidence suggested that the costs of prohibition exceeded its benefits. Personal experience can be powerful but misleading. What happened in one family doesn't necessarily generalise to effective policy.

for an entire society. Other children of addicted parents became advocates for treatment and harm reduction, recognizing that punishment hadn't helped their parents and might have made things worse. They channeled their family experience

into working for more humane and effective approaches to addiction. The addiction crisis created an entire generation of people personally affected by drug use and their varying responses to that experience shaped drug policy debates

for the rest of the century. The cultural response to the hero in crisis also left lasting marks, particularly in art and literature. The 1920s and 30s saw an explosion of cultural production dealing with themes of addiction, with much of it serving as warning about the dangers of drug use. Novels depicted the descent of addicts from respectable life into degradation and death. Plays dramatized the destruction of families by drug use. Visual artists created works depicting the human cost of addiction gaunt faces, collapsed bodies, the physical and spiritual devastation.

Some of this work was genuinely powerful art that helped people understand addiction as human tragedy rather than just moral failing, but much of it was sensationalised and moralistic, designed to shock people into avoiding drugs rather than to foster genuine understanding of addiction. The cultural narrative that developed around drugs in this period emphasised danger, degradation and death,

all of which were real risks, while largely ignoring the more complex realities of how and why people use drugs and what might actually help them. The jazz culture that we discussed earlier left a complicated legacy. On one hand, it produced some of the most important music of the 20th century, much of it created by people struggling with addiction. On the other hand, it reinforced associations between drug use and artistic creativity that would persist for decades and mislead generations of young artists into thinking drugs were paths to enhance creativity, rather than traps that destroyed creative potential. The romanticisation of the tortured artist who creates

while high became a cultural trope with real consequences. People would use drugs thinking they were following in the footsteps of artistic geniuses, not recognising that most of those geniuses had created their best work despite their drug use, not because of it. The scientific legacy was more productive. The addiction crisis of the 1920s spurred research into the neurobiology of addiction, the pharmacology of opioids and the treatment of substance use disorders. Progress was slow neuroscience was in its infancy, and studying illegal drugs presented obvious practical and ethical challenges, but the foundation was laid for the addiction medicine that would develop throughout the 20th century. Researchers who'd observed the crisis recognized that addiction was a legitimate field of medical inquiry, not just a moral

issue, and their work gradually built the knowledge base that informs modern addiction treatment. The public health infrastructure that eventually emerged to address addiction treatment centres, needle exchanges, overdose prevention programmes, developed partly in response to the failures of prohibition as implemented in places like Paris in the 1920s. It took decades for these approaches to gain acceptance and implementation, but the seeds were planted by people who'd witnessed prohibition's catastrophic effects and recognised that alternative approaches were necessary. The harm reduction movement that would become influential in the late 20th century traced its intellectual lineage back to these early observations that reducing harm was more

achievable and more humane than eliminating drug use through prohibition. The international drug trafficking networks that consolidated during this period left perhaps the most durable legacy. The organisational structures, smuggling routes, money laundering techniques and corruption strategies developed in the 1920s and 30s became the template for drug trafficking throughout the rest of the century. The French connection, the Latin American cartels, the Asian heroin trade-all built on foundations established in this earlier period. The decision to prohibit drugs globally created conditions that fostered the development of powerful, sophisticated criminal organizations that would prove extraordinarily difficult to dismantle, and that would cause enormous harm

through violence, corruption, and the inherent dangers of illegal drug markets. Looking back at the entire arc from the mid-1920s through the 1930s, from easy pharmaceutical access to strict prohibition to depression-era catastrophe. It's difficult to identify any aspect of drug policy that worked as intended. The initial pharmaceutical marketing created addiction epidemic. Prohibition transformed a managed health crisis into a chaotic criminal market with increased mortality. The depression multiplied the suffering of the most vulnerable. The international response exported failed policies globally, rather than learning from mistakes. The lasting legacy was more harm, more criminality, more suffering, and more entrenched problems that would resist solutions for generations.

The parallel to modern drug policy is uncomfortable, but undeniable. We're still fundamentally operating under the prohibition framework established nearly a century ago, still pursuing the same failed strategies, still creating the same harms, still refusing to learn from extensive historical evidence that prohibition doesn't work. The opioid epidemic of the early 21st century rhymes almost perfectly with the heroin crisis of the 1920s, pharmaceutical companies aggressively marketing addictive drugs, doctors prescribing liberally, patients becoming addicted, eventual crackdown creating illegal markets with more dangers, increased mortality and policy responses that increase harm while claiming to reduce it.

The details differ, but the fundamental patterns remain depressingly consistent. The question that emerges from studying this history is, Why do we keep making the same mistakes? Part of the answer is that drug policy is driven more by moral convictions and political considerations than by evidence of what actually works. Prohibition feels right emotionally. Drugs are bad, therefore they should be banned, even when evidence shows prohibition creates worse outcomes than alternative approaches.

Politicians gain more from appearing tough on drugs than from implementing effective but politically unpopular policies. The institutional momentum behind prohibition is enormous, and changing course would require admitting that a century of drug policy has been fundamentally misguided. But another part of the answer is that the systems created by prohibition have developed their own constituencies and interests. Law enforcement agencies depend on drug enforcement for funding and mission. Private prisons profit from incarcerating drug offenders.

Criminal organisations rely on prohibition inflated drug prices for their revenue. Treatment providers working within abstinence-only frameworks resist harm-reduction approaches that might reduce demand for their services. Politicians build careers on drug war rhetoric. There are powerful interests invested in maintaining prohibition even if it doesn't work, because it works for them even if it fails for society. The story of heroin in 1920s Paris is ultimately a story about system failure at multiple levels. Medical, regulatory, social, political. Each component of the system made decisions that seemed rational in isolation, but combined to produce disaster. Pharmaceutical companies marketed aggressively because that's what companies do.

Doctors prescribed based on incomplete knowledge because that's the best they could manage with available information. Regulators implemented prohibition because political pressure demanded action. Law enforcement pursued criminals because that's their mandate. Each actor following their incentives, each decision seeming reasonable, the collective result being catastrophe. Breaking out of these system failures requires not just better individual decisions but actually restructuring the systems themselves, changing incentives, reallocating resources,

reimagining what drug policy could look like if it prioritised health and harm reduction over punishment and prohibition. That kind of systematic change is extraordinarily difficult to achieve, which is why we're still living with the consequences of decisions made in Paris a century ago, still fighting drug wars that were lost before they began, still sacrificing lives to policies that don't work and never have. So here we are, at the end of this journey through one of history's most elegant disasters. We've watched Paris transform from the City of Light into something approaching a case study and how systems can fail spectacularly, while everyone involved insist they're

doing everything right. We've seen pharmaceutical companies market addiction as medicine. Doctors prescribe catastrophe with the best intentions. Artists destroy their talents in pursuit of inspiration. Wealthy elites inject themselves with silver syringes while maintaining their simply being responsible about their health, and politicians respond to every problem by making it worse while claiming victory. It's been, shall we say, educational in ways that make you wonder whether humans are actually capable of learning from experience, or if we're just condemned to repeat the same mistakes with increasingly sophisticated justification.

But before you drift off to sleep, and I genuinely hope you do. This has been a long night together. I want to leave you with a question that matters far more than the historical details we've been exploring. The question isn't really about heroin, or about Paris, or even about the 1920s. Those are just the specific circumstances where a more fundamental pattern played out with particular clarity. The real question is this. What's more dangerous, the substance itself, or the system that makes consuming that substance seem like a reasonable, even rational choice? Think about what we've actually witnessed in this story. Heroin is certainly a dangerous drug nobody's disputing that. It's highly addictive. It can kill you

through overdose or through the various complications of long-term use, and once you're dependent on it, escaping that dependence is extraordinarily difficult. But heroin didn't force itself on anyone. It didn't leap out of bottles and inject itself into people's veins while cackling maniacly. Every person who ended up addicted made a series of choices that seemed reasonable, given the information they had and the context they were operating in. Marguerite didn't wake up one morning and think, You know what would really improve my life? Developing a severe drug addiction that will destroy my career, my relationships, and possibly kill me. She went to a doctor because she had legitimate symptoms.

The doctor prescribed what was presented as safe, effective medicine. She took it as directive. She bought it from reputable pharmacies in elegant bottles with professional labels. Every step of the way, she was following what appeared to be sound medical advice, using products that were legal and socially acceptable, making choices that thousands of other people were making simultaneously. The system told her this was fine, and she trusted the system because why wouldn't you? Systems are supposed to be trustworthy.

That's kind of their whole job. The artist in Montmart, the jazz musicians in basement clubs, the wealthy women in their salons, none of them thought they were making catastrophically bad decisions. They were managing their anxiety, enhancing their creativity, treating their insomnia, addressing their nerves. They were using tools that society had made available, and that authority figures had endorsed. The fact that these tools would eventually destroy many of them wasn't visible in advance, or if it was visible, it was dismissed as something that happened to other people, people who weren't as careful or responsible or strong-willed.

This is the really insidious part of the system we've been examining. It didn't feel dangerous from inside. The elegant pharmacy with its marble counters and professional pharmacist looked like exactly the kind of place where you'd obtain safe, effective healthcare. The medical textbooks describing heroin as appropriate therapy had the weight of scientific authority. The pharmaceutical advertisements in respected journals appeared to be providing legitimate medical information.

The doctors prescribing heroin had years of training and prestigious credentials. At every level, the system was sending signals of safety, legitimacy and respectability. The danger was disguised so effectively that even people directly experiencing harm often couldn't recognise it for what it was. And here's where we need to get uncomfortable about the present, because this pattern isn't historical, it's recurring. Right now, today, there are systems of... operating that make harmful choices seem reasonable. Pharmaceutical companies are marketing drugs that

will create dependencies while insisting they're safe when used as prescribed. Doctors are prescribing medications based on incomplete information and pharmaceutical company guidance. Regulatory agencies are approving drugs without fully understanding long-term consequences. Advertising is creating needs and selling solutions that may actually be problems in disguise. We know this happens because we've watched it happen repeatedly, with barbiturates, with benzodiazepines, with oxycontin, and the prescription opioid epidemic that's killed hundreds of thousands of people in the last few decades alone. The question isn't whether you personally would ever use heroin, or whether derogs are bad. Those are easy questions with obvious answers. The harder question is,

how do you recognise when a system is steering you toward harm while insisting it's helping you? How do you maintain skepticism about authoritative claims when authorities are used? You usually, mostly genuinely trying to be helpful? How do you distinguish between legitimate medical care and pharmaceutical marketing disguised as medical care? How do you know when experts actually understand what they're talking about versus when they're overconfident about incomplete knowledge? These aren't theoretical questions. You're navigating systems right now that are trying to influence your behaviour, your consumption, your choices. Some of those influences are benign or helpful. Others are absolutely not. The challenge is figuring out which is which is which.

when the harmful influences have learned to disguise themselves as helpful ones. Pharmaceutical ads don't say, take this drug that might addict you and ruin your life. They say, ask your doctor if this medication is right for you, accompanied by images of happy, healthy people, living their best lives thanks to the product being advertised. The harm is packaged as help, and it's wrapped so beautifully that spotting the danger

requires active effort and skepticism. Paris in the 1920s teaches us that systems can fail catastrophes. while appearing to function normally. The pharmacies kept selling products. The doctors kept prescribing. The pharmaceutical companies kept manufacturing. The money kept flowing. From inside the system, everything looked fine.

Business was good, patients were satisfied, profits were healthy. The failure was only visible when you stepped back far enough to see the human wreckage accumulating. And even then, the system resisted acknowledging the failure, because doing so would require admitting systematic error and accepting institutional responsibility. The other lesson Paris teaches us is about scientific humility, or rather the catastrophic consequences of lacking it. The doctors prescribing heroin were confident they understood what they were doing. The pharmaceutical companies were certain their products were safe. The medical establishment was sure their guidelines were based on solid evidence. This confidence was misplaced. They were operating with partial knowledge, making claims

that went far beyond what they actually understood, but the confidence itself was part of what made the system so dangerous. If you're uncertain about whether a treatment is safe, you're cautious about prescribing it. If you're confident it's safe based on incomplete evidence, you prescribe it liberally and then struggle to revise your position when contradictory evidence emerges. We see this same overconfidence in modern contexts.

New pharmaceutical products are introduced with enormous confidence about their safety and efficacy, based on relatively short-term studies that can't possibly capture long-term effects or rare complications. Doctors prescribe based on that confident marketing, and patients consume based on trust in medical authority. Sometimes the confidence is justified and the products are genuinely helpful. Sometimes the confidence is premature and we discover problems only after widespread use has already created harm. The challenge is that you can't tell the difference in advance. Overconfidence looks exactly the same as justified confidence until time proves one or the other.

The normalisation process we've watched unfold in Paris is particularly worth understanding because it's a pattern that repeats with remarkable consistency. Something starts as a marginal practice, maybe controversial, maybe experimental, maybe restricted to specific populations, then it expands. More people do it. Authorities endorse it. It appears in mainstream venues. social proof accumulates. If everyone's doing it, it must be okay. Before long, what was once questionable becomes normal, and questioning it becomes the controversial position. We watch this

happen with heroin in Paris. It's happened with countless other substances and practices throughout history. It's happening right now with various things that future historians will probably look back on and wonder what we were thinking. The system that made heroin seem like a reasonable choice in 1920s. Paris wasn't one giant conspiracy. It was thousands of individual actors following their incentives, making locally rational decisions that collectively produced disaster. Pharmaceutical companies wanted to profit, which meant marketing aggressively. Doctors wanted to help patients, which meant prescribing available treatments. Patients wanted relief from suffering, which meant using whatever medicine was recommended. Regulators wanted

to appear effective, which meant implementing policies that look decisive regardless of whether they actually worked. Each component of the system was doing what systems do, and the emergent result was catastrophic. This is why focusing solely on individual responsibility or personal choice misses the point. Yes, individuals made choices, but they made those choices within a system that shaped what options seemed available and reasonable. You can't have thousands of people all simultaneously making the same terrible decisions unless there's something systematic creating conditions where those decisions make sense. Blaming individuals for addiction while ignoring the system that produced addiction is like blaming people for getting wet in a rainstorm while refusing to acknowledge that it's

raining. Technically true that they could stay dry by not going outside, but missing the larger picture about what's actually happening. So what do we do with this knowledge? How do you navigate systems that might be steering you wrong while insisting they're helping you. There's no perfect answer, which is frustrating but honest, but there are some principles worth considering. Maintain skepticism, especially toward claims that something is completely safe or that you need to act immediately without time for consideration. Be cautious about products that are heavily marketed. Aggressive marketing often means the product needs marketing to succeed rather than succeeding on its own merits. Pay attention to conflicts of interest, who's making money from you making particular choices,

and might that be colouring the advice you're receiving? Question confidence, especially from people who should be uncertain. Medical science advances constantly, which means current knowledge is always incomplete. Doctors and researchers who acknowledge uncertainty are often more trustworthy than those who claim complete confidence about complex issues. Look for people who say, we don't fully understand this yet, rather than we figured it all out. The former is more likely to be accurate, even if the latter is more reassuring. Notice patterns in how problems are framed and solutions are offered. When you're told you have a condition you didn't know you had,

and conveniently there's a product available to treat it, consider the possibility that the condition was defined to create a market for the product. Not always, sometimes genuine medical conditions get recognized and named, but sometimes the disease is invented to sell the cure. Medical anthropologists call this disease mongering, and it's been a pharmaceutical industry strategy for decades, and perhaps most importantly remember that systems optimize for what they measure and reward.

If a pharmaceutical company is rewarded primarily for profits, it will optimize for profits, and safety will be secondary to the extent it interferes with profitability. If a doctor is rewarded for patient satisfaction and prescribing medications makes patients satisfied, the doctor will prescribe, even if prescribing isn't always the best medical decision. If regulatory agencies are judged by how many drugs they approve rather than how well those drugs work, they'll optimize for approvals.

Understanding incentives helps you understand why systems behave as they do and why they might not have your best interest as their primary concern. None of this means you should distrust everything, or refuse all medical treatment or become paranoid about systems trying to harm you. Most of the time, systems work reasonably well, and most people in those systems are trying to be helpful. But sometimes systems fail catastrophically while appearing to function normally, and sometimes the people who are sure they're helping are actually causing harm, and being able to recognise those situations before you become a casualty,

requires critical thinking and healthy skepticism. The story of Paris in the 1920s is ultimately a story about what happens when we collectively fail to ask hard questions, fail to acknowledge uncertainty, fail to learn from early warning signs, and fail to hold systems accountable for the harms they create. It's a story about how good intentions and confident assertions can pave roads to terrible destinations.

It's a reminder that progress isn't inevitable, that new isn't always better, that medical science can be wrong, and that sometimes the most respectable-looking systems are the most dangerous precisely because their respectability discourages the skepticism that might protect us. As you're falling asleep tonight, I hope this story stays with you not as a nightmare

but as a framework for thinking about the world you're navigating every day. The systems that shaped heroin use in 1920s Paris aren't gone. They've just changed their products and updated their marketing. The patterns of normalisation, the overconfident expertise, the corporate interest disguised as medical guidance, the regulatory capture,

the difficulty in acknowledging systematic fail, all of that persists. Being able to recognise these patterns gives you at least a chance of avoiding the traps they create, and maybe, just maybe, if enough people start asking better questions and demanding better answers and refusing to accept confident assertions as substitutes for actual knowledge, we can build systems that are actually designed to serve human well-being rather than systems that serve corporate profits while using human well-being as marketing language. That's probably optimistic, systems are hard to change and powerful interests benefit from maintaining the status quo, but it's a more pleasant thought to sleep on than the alternative. So here's my final question

for you before you drift off. What systems in your own life are you trusting without fully examining? What authorities are you accepting without questioning? What choices are you making because they seem normal and reasonable, not because you've carefully evaluated whether they're actually good for you? Where might you be, Marguerite, walking into a pharmacy in 1925, confident that the system is helping you, not yet aware that you're participating in your own destruction. Think about it. Question it. Stay skeptical. Trust yourself to ask hard questions even when the answers are uncomfortable. And remember that the most dangerous thing about Paris in the 1920s wasn't the heroin. It was the system that convinced everyone heroin was fine. All right, we've been together for hours

now, wandering through this dark historical landscape, and I think we've earned some rest. Thank you for staying with me through this story. I know it wasn't always easy to hear. Human suffering rarely is, but I hope it was worth your time, hope it gave you something to think about beyond just the historical facts. History isn't just about what happened. It's about understanding patterns that persist, about recognising when we're repeating mistakes, about learning to see the present more clearly by understanding the past. Sleep well tonight, wherever you are in the world. Let your mind process what you've heard. dream about better systems and healthier societies, and a future where we've actually learned from

our mistakes, instead of just repeating them with better technology. And tomorrow, when you wake up, maybe look at the world around you with slightly more skeptical eyes, asking better questions about the systems you're navigating, and the choices you're being encouraged to make. Good night, sweet dreams. And remember, stay curious, stay skeptical, and never trust a system that insists you should stop asking questions. Until next time, take care of yourselves out there.